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ABSTRACT 
Chemical investigation of the transformation of the crucifer phytoalexins 
brassinin, brassilexin and camalexin by the phytopathogenic fungus Alternaria 
brassicicola was carried out. The objectives of this study included: i) the isolation and 
characterization of the metabolites of biotransformation of brassinin (2), brassilexin (21) 
and camalexin (24) by A. brassicicola; ii) determination of the antifungal activity of 
these phytoalexins and their metabolites against A. brassicicola. 
The phytoalexins were synthesized and characterized using HPLC retention time 
tR, 1H NMR, 13C NMR, LC-MS and HRMS-ESI data. The metabolites of the 
biotransformation were also synthesized and characterized similarly. The metabolism of 
each phytoalexin and their metabolites was studied by analyzing broth extracts by 
HPLC. The percent inhibition of growth of A. brassicicola was determined by radial 
growth mycelial assays. 
The biotransformation of brassinin (2) by A. brassicicola afforded Nb-acetyl-3-
indolylmethylamine (46) via indole-3-methylamine (45) intermediate. Brassilexin (21) 
was metabolized to 3-(amino)methyleneindoline-2-thione (67) by the reduction of the 
isothiazole ring. Camalexin did not appear to be metabolized or the metabolism was very 
slow. The results of biotransformation and bioassay studies established that the 
metabolism of brassinin by A. brassicicola was a detoxification process. However, these 
studies using brassilexin (21) did not provide a rigorous conclusion. Camalexin showed 
strong inhibition of growth against A. brassicicola suggesting its importance in defense 
against this pathogen. 
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CHAPTER 1: INTRODUCTION 
1.1 General objectives 
Alternaria brassicicola (Schweinitz) Wiltshire is the causative agent of 
blackspot disease in a wide range of crucifer species in Canada and worldwide. The aim 
of my research project was to investigate the biological activities and biotransformations 
of crucifer phytoalexins by the blackspot fungus A. brassicicola. The chemical 
investigation of the metabolism of phytoalexins by A. brassicicola and evaluation of 
their antifungal activity will allow a better understanding of the role of phytoalexins in 
plant fungal diseases. My overall objectives included:  
i) Biotransformations of the crucifer phytoalexins brassinin (2), brassilexin (21) 
and camalexin (24) by the phytopathogenic fungus A. brassicicola.  
ii) Determination of the antifungal activity of these phytoalexins and their 
metabolites against A. brassicicola. 
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1.2 Crucifer phytoalexins 
Phytoalexins are secondary metabolites produced de novo by plants in response 
to various forms of biotic and abiotic stress including microbial attack (Pedras et al., 
2007a). The term phytoalexin was introduced to describe induced antibiotic plant 
metabolites and is derived from the Greek words phyton = plant and alexein = protecting 
substance (Müller and Börger, 1940). The first phytoalexin, pisatin (1), was isolated 
from Pisum sativum (pea) infected with Sclerotinia fructicola (Cruickshank and Perrin, 
1960). 
O
O
O
O
OH
H
H3CO
 
Figure 1.1 Chemical structure of pisatin (1). 
 
After discovery of the first phytoalexin, many other phytoalexins were 
identified belonging to different plant families. Phytoalexins from the same family of 
plants possess structural features indicating the same biosynthetic origin (Macías et al., 
2007). Closely related plants produce phytoalexins of similar structures. For example, 
plants from Leguminosae produce predominantly isoflavanoid phytoalexins (Harborne, 
1999; Ingham, 1982), plants from Solanaceae synthesize  mostly terpenoid phytoalexins 
(Brooks and Watson, 1991; Jadhav et al., 1991), plants from Caryophyllaceae 
accumulate phytoalexins derived from anthranilamide (Niemann, 1993), and cruciferous 
plants accumulate sulfur containing indole phytoalexins (Pedras et al., 2003a; 2007a). 
1 
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The biosynthetic precursor of crucifer phytoalexins, including camalexins (Glawischnig 
et al., 2004) is tryptophan (Pedras et al., 2003a, b). 
Brassicaceae (Cruciferae), commonly known as crucifers, is the largest plant 
family in the plant kingdom. Crucifers are an economically important group of plants 
since they are used as vegetables, oil sources and condiments. Brassicaceae contains 
approximately 350 genera and about 3,700 species according to the Royal Botanic 
Gardens, Kew, England (Lawrence et al., 2008). Crucifer plants are present in almost 
every part of the world from tropics to the Arctic Circle. The greatest numbers of genera 
are abundant in temperate zones of the northern hemisphere. 
 
1.2.1 Structures and biological activity 
Phytoalexins from crucifers were first reported in 1986 by Takasugi and co-
workers (Takasugi et al., 1986). Brassinin (2), 1-methoxybrassinin (4), and 
cyclobrassinin (12) were isolated from Chinese cabbage (B. campestris L. ssp. 
pekinensis) infected with Pseudomonas cichorii (Takasugi et al., 1986). After 
Takasugi’s report, close to 40 crucifer phytoalexins were isolated and reported (Figure 
1.2) (Pedras et al., 2007a). The general structural feature of crucifer phytoalexins is the 
presence of indole or oxindole ring with substituents containing sulfur or nitrogen or 
both. The non-sulfur containing phytoalexins are 1-methoxyindole-3-carboxylate (9), 
isalexin (39), arvelexin (18), caulilexin B (41) and caulilexin C (17). Erucalexin (40) 
isolated from dog mustard (Erucastrum gallicum) is the first phytoalexin to have a 
  4 
carbon substituent at C-2, whereas all other phytoalexins have carbon substituents at C-
3. It is interesting that only cruciferous phytoalexins contain a dithiocarbamate or 
thiocarbamate group (2, 3, 4, 5, 6) are similar to widely used synthetic fungicides 
(Pedras et al, 2007a). Caulilexin A (10) is the first phytoalexin to possess a disulfide 
bridge (Pedras et al., 2006a). The first naturally occurring aromatic isothiocyanates, 
rapalexins A (36) and B (37), were isolated from B. rapa (canola) (Pedras et al, 2007a ; 
Pedras et al., 2007b). Wasalexins A (27) and B (28) were isolated from wasabi (Wasabia 
japonica syn. Eutrema wasabi) (Pedras et al., 1999; Pedras et al, 2007a), arvelexin (18) 
was isolated from Thlaspi arvense (stinkweed) (Pedras et al., 2003a; Pedras et al, 
2007a), isalexin (39), brassicanate A (11), and rutalexin (23) were isolated from B. 
napus, ssp. rapifera (rutabaga) (Pedras et al., 2004b; Pedras et al, 2007a), sinalbins A 
(14) and B (15) were first isolated from white mustard (Sinapis alba) (Pedras and 
Zaharia, 2000; Pedras et al, 2007a), brassicanals A (7), B (20) and C (8) were isolated 
from Chinese cabbage (Monde et al., 1990; Monde et al., 1991; Pedras et al, 2007a), 
camalexins (24, 25, 26) were isolated from Camelina sativa (Ayer et al., 1992; Pedras et 
al, 2007a), brassilexin (21) was isolated from Brassica juncea (Devys et al., 1988; 
Pedras et al, 2007a), sinalexin (22) was isolated from white mustard (Sinalpis alba) 
infected with A. brassicae or elicited with CuCl2 (Pedras and Smith, 1997; Pedras et al, 
2007a), brussalexin A (35) was isolated recently from brussels sprouts (B. oleracea var. 
gemmifera) (Figure 1.2) (Pedras et al., 2007c). Brussalexin A (35) is the first phytoalexin 
containing an allyl thiolcarbamate group. 
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Figure 1.2 Crucifer phytoalexins: brassinin (2); brassitin (3); 1-methoxybrassinin 
(4); 4-methoxybrassinin (5); 1-methoxybrassitin (6); brassicanal A (7); brassicanal C (8); 
methyl 1-methoxyindole-3-carboxylate (9); caulilexin A (10); brassicanate A (11); 
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cyclobrassinin (12); cyclobrassinin sulfoxide (13); sinalbin A (14); sinalbin B (15); 
indole-3-acetonitrile (16); caulilexin C (17); arvelexin (18); dioxibrassinin (19); 
brassicanal B (20); brassilexin (21); sinalexin (22); rutalexin (23); camalexin (24); 1-
methylcamalexin (25); 6-methoxycamalexin  (26); wasalexin A (27); wasalexin B (28); 
1-methoxybrassenin A (29); 1-methoxybrassenin B (30); 1-methoxyspirobrassinin (31); 
spirobrassinin (32); 1-methoxyspirobrassinol (33); 1-methoxyspirobrassinol methyl ether 
(34); brussalexin A (35); rapalexin A (36); rapalexin B (37); dehydro-4-
methoxycyclobrassinin (38); isalexin (39); erucalexin (40); caulilexin B (41) (Pedras et 
al., 2007a; 2007b, 2007c). 
 
Crucifer phytoalexins are bioactive plant products having inhibitory properties 
against different species of fungi. Crucifers under fungal attack, produce a complex 
blend of antimicrobial metabolites as induced chemical defenses. The rate of production 
and the amount of production of defense chemicals can affect plant resistance against 
pathogen invasion (Smith, 1996). Research studies using in situ localization and 
quantification revealed that phytoalexins can accumulate at the right time, concentration 
and location in plant tissues (Hammerschmidt and Dann, 1999). Antifungal activity of 
crucifer phytoalexins has been investigated using different bioassays (Pedras et al., 
1998). Most crucifer phytoalexins are active against fungal pathogens at 0.1-0.5 mM. 
Brassinin (2) exhibited complete inhibition of spore germination of Leptosphaeria 
maculans and complete mortality of shrimp larvae (Artemia salina) at 0.5 mM (Pedras 
and Jha, 2006; Pedras et al., 2007a). Brassitin (3) was isolated from Japanese radish 
roots (Raphani sativus var. hortensis) elicited by Pseudomonas cichorii and was 
detected by inspection of its antifungal activity in a TLC bioassay (Monde et al., 1995). 
Brassitin (3) was sprayed onto leaves of B. oleracea for testing its influence on the 
oviposition behavior of cabbage fly, Delia radicum (L.) (Baur et al., 1998). Brassicanal 
  7 
A (7) and brassicanal C (8) showed growth inhibition of ca. 70%, 50% and 30% in radial 
growth antifungal bioassays against L. maculans, Rhizoctonia solani and Sclerotinia 
sclerotiorum, respectively at a concentration of 0.5 mM (Pedras et al., 2006a; 2007a). 
Caulilexin A (10) displayed 50% growth inhibition against L. maculans whereas 
complete inhibition was observed against S. sclerotiorum and R. solani at the same 
concentration of 0.5 mM (Pedras et al., 2006a; 2007a). Caulilexin B (41) showed 
significantly less inhibition against L. maculans, S. sclerotiorum and R. solani at a 
concentration of 0.5 mM (Pedras et al., 2006a; 2007a). Caulilexin C (17) exhibited 75% 
and 30% inhibition against L. maculans and S. sclerotiorum, respectively, but complete 
inhibition against R. solani (Pedras et al., 2006a; 2007a). Brassicanate A (11) showed 
complete inhibition against L. maculans, S. sclerotiorum and R. solani at a concentration 
of 0.5 mM (Pedras et al., 2004a; 2007a). Cyclobrassinin (12) and spirobrassinin (32) 
showed strong inhibition against mycelial growth of A. brassicae and spore germination 
of Cladosporium cucumerinum, but these phytoalexins exhibited moderate antifungal 
activities against L. maculans, R. solani, S. sclerotiorum, Botrytis cinerea, Fusarium 
nivale and Pythium ultimum (Dahyia and Rimmer, 1988). Brassilexin (21) was found 
more inhibitory than brassinin and cyclobrassinin. Complete mycelial growth inhibition 
was observed against L. biglobosa, L. maculans and S. sclerotiorum at a concentration of 
0.5 mM (Pedras et al., 2000; Pedras and Hossain, 2006; Pedras et al., 2007a). Camalexin 
(24) caused complete inhibition of various crucifer pathogens even at lower 
concentrations than brassilexin (Pedras et al., 2004a; Pedras and Khan, 2000; Pedras and 
Ahiahonu, 2002; Pedras et al., 2007a). Wasalexin A (27) and wasalexin B (28) exhibited 
antifungal activity against L. maculans causing ca. 50% spore germination inhibition 
(Pedras et al., 1999; Pedras et al., 2007a). Arvilexin (18) displayed 35%, 60% and 70% 
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inhibition in mycelial growth bioassays against S. sclerotiorum, L. maculans and R. 
solani respectively at a concentration of 0.5 mM (Pedras et al., 2006a; Pedras et al., 
2007a). Sinalbin A (14) and sinalbin B (15) exhibited spore germination inhibition 
against L. maculans at 0.5 mM (Pedras and Zaharia, 2000; Pedras et al., 2007a). 
Rapalexin A (36) and B (37) were investigated for the inhibition of spore germination of 
Albugo candida; rapalexin A (36) was more inhibitory than rapalexin B (37) (Pedras et 
al., 2007b; Pedras et al., 2007a). Brussalexin A (35) showed higher inhibition against S. 
sclerotiorum than A. brassicicola, L. maculans and R. solani at 0.5 mM concentration 
(Pedras et al., 2007c). Erucalexin (40) exhibited complete inhibition against R. solani 
and only 40% inhibition against S. sclerotiorum in mycelial radial growth bioassays at 
0.5 mM (Pedras et al., 2006b; Pedras et al., 2007a). Isalexin (39) displayed antifungal 
activity only against L. maculans in radial growth bioassay at 0.5 mM concentration 
while S. sclerotiorum and R. solani did not exhibit growth inhibition (Pedras et al., 
2004a; Pedras et al., 2007a).  
 
Crucifer phytoalexins appear to be cancer chemopreventive, antiproliferative 
and antitumor agents (Banerjee et al., 2008; Mezencev et al., 2003; Pilatova et al., 2005). 
Epidemiological studies suggest that cancer risk is reduced if crucifer vegetables are 
consumed in the diet (Pedras, 2008 and references within). The protective effect of the 
crucifer vegetables is due to the active metabolites produced by crucifer family such as 
isothiocyanates and indole-containing compounds (Glawischnig, 2007 and references 
within; Pedras, 2008). Metabolic detoxification of carcinogens undergoes three stages: i) 
activation of carcinogen by oxidation (Phase I); ii) conjugation to a more polar structure 
(Phase II); iii) ultimate excretion of the xenobiotics from the cell (Phase III).  
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Brassica diets have potential to increase the oxidative metabolism (Phase I) and 
to induce Phase II enzymes (Johnson et al., 1995; Mehta et al., 1995; Talalay et. el., 
1995). Brassinin (2), cyclobrassinin (12) and spirobrassinin (32) inhibited mammary 
lesion formation in the mouse mammary gland organ culture model (Mehta et al., 1994). 
Cancer chemopreventive activity of brassinin (2) was also investigated by Mehta and 
coworkers in a dose-dependent experiment (Mehta et.al., 1995). Studies have been 
carried out to develop cancer chemopreventive drugs from derivatives of indole 
phytoalexins (Mezencev et al., 2008). Synthetic analogs of phytoalexins have also been 
investigated by Pedras’ group for designing “PALDOXIN” (PhytoALexin 
DetOXification INhibitor) toward the control of fungal diseases of crucifers (Pedras, 
2008; Pedras et al., 2007a; Pedras et al., 2003b). 
 
1.2.2 Biotransformation of brassinin, brassilexin and camalexin by plant 
pathogenic fungi 
Detoxification is a process by which toxic metabolites are converted to less 
toxic or even nontoxic metabolites. Phytoalexins are toxic towards fungi, bacteria as 
well as plant cells (Darvill and Albersheim, 1984; Marinelli et al., 1995). Fungal cell 
membranes are most likely the site for toxic action of phytoalexins (Paxton, 1979; 
Smith, 1996), although the mode of action of phytoalexins has not been reported 
extensively. It is very likely that there are multiple modes of action for the disruption of 
cell membranes (Smith, 1996). Phytoalexins are very diverse in their structural variety 
and thus their toxicity covers a range of 10-6 to 10-4 M for inhibition.  However, fungal 
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pathogens can void plant chemical defenses through metabolic detoxification and 
biotransformation (Pedras and Ahiahonu, 2005). As a result, plants become susceptible 
to pathogens. For fungal disease control, it is important to know how the fungus destroys 
or voids the defense chemicals through metabolic detoxification. A possible strategy for 
controlling fungal diseases is the inhibition of enzymes involved in the detoxification of 
phytoalexins (Pedras et al., 2004a). Biotransformation studies may open the opportunity 
to design inhibitors of these enzymatic reactions. 
 
1.2.2.1  Brassinin and related compounds 
Biotransformations of brassinin and related compounds have been studied 
extensively in Pedras’ group using phytopathogenic fungi L. maculans, L. biglobosa, S. 
sclerotiorum, R. solani and A. brassicae. Biotransformation studies of brassinin (2) and 
its homologues using L. maculans and L. biglobosa (Pedras and Ahiahonu, 2005; Pedras 
and Okanga, 2000; Pedras, 2008; Pedras and Taylor, 1993) showed that the metabolism 
takes place only in the side chain (Scheme 1.1). The biotransformation of brassinin (2) 
by L. maculans, virulent on canola, led to the formation of indole-3-carboxylic acid (43) 
via indole-3-carbaxaldehyde (42). Metabolism of brassinin (2) by L. biglobosa, avirulent 
on canola, took place via indole-3-methylamine (45) and Nb-acetyl-3-
indolylmethylamine (46) to indole-3-carboxylic acid (43) (Pedras and Taylor, 1991; 
Pedras and Taylor, 1993). However, biotransformation of brassinin (2) by the stem rot 
fungus S. sclerotiorum was completely different yielding an N-glucosylated product, 1-
β-D-glucopyranosylbrassinin (44), without affecting the dithiocarbamate moiety (Pedras 
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and Ahiahonu, 2005; Pedras and Hossain, 2006; Pedras et al., 2004a). The presence of 
(─NH─) moiety on the side chain of brassinin is the key for brassinin detoxification. In 
addition, research suggested that the removal of methylene bridge or the replacement of 
the (N)─H with an (N)─CH3
L. maculans
N
H
H
N SCH3
S
N
H
CHO
N
H
COOH
L. maculans
N
H
CHO
N
H
COOH
N
H
H
N
R
R=H
L. biglobosa
L. biglobosaL. biglobosa
S. sclerotiorum
N
H
N SCH3
S
O
OH
HO
HO
HO
R=Ac
 group could inhibit degradation of dithiocarbamates 
(Pedras, 2008). Brassinin (2) metabolism by phytopathogenic fungi L. maculans, L. 
biglobosa and S. sclerotiorum is presented in Scheme 1.1. 
 
 
Scheme 1.1 Detoxification of brassinin (2) by Leptosphaeria maculans, 
Leptosphaeria biglobosa and Sclerotinia sclerotiorum (Pedras and Ahiahonu, 2005; 
Pedras et al., 2007d). 
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45 
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The selectivity of enzymes involved in this detoxification process was 
investigated using several analogs of brassinin (Pedras and Okanga, 1998, 2000; Pedras 
et al., 2004a). The metabolism of the brassinin analog, methyl tryptamine 
dithiocarbamate (49) by L. maculans, virulent on canola led to the formation of indole-3-
acetic acid (48) as final product via indole-3-acetaldehyde (47) and another product 3a-
hydroxy-3,3a,8,8a-tetrahydropyrrolo[2,3-b]indol-1(2H)-yl carbodithioate (50), whereas 
L. biglobosa, avirulent on canola, metabolized methyl tryptamine dithiocarbamate (49) 
to indole-3-acetic acid (48) via tryptamine (51) and Nb
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-acetyltryptamine (52) (Pedras 
and Okanga, 1998, 2000), as shown in Scheme 1.2.  
 
 
Scheme 1.2 Detoxification of methyl tryptamine dithiocarbamate (49) by 
Leptosphaeria maculans and Leptosphaeria biglobosa (Pedras and Ahiahonu, 2005; 
Pedras and Okanga, 1998, 2000). 
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Similar to previous studies, metabolism of methyl tryptamine dithiocarbamate 
(49) by A. brassicae provided Nb
R=H
S. sclerotiorum
N
H
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NHR
NO
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HO
HO
HO
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S
N
H
NH
SCH3
S
R=Ac
-acetyltryptamine (52) as the major product and 
tryptamine (51) as minor product (Pedras and Okanga, 1998, 2000). Metabolism of 
methyl tryptamine dithiocarbamate (49) by S. sclerotiorum yielded N-glucosylated 
product of methyl tryptamine dithiocarbamate (53) (Pedras et al., 2004a) as shown in 
Scheme 1.3. 
 
 
Scheme 1.3 Detoxification of methyl tryptamine dithiocarbamate (49) by Alternaria 
brassicae and Sclerotinia sclerotiorum (Pedras and Okanga, 1998, 2000; Pedras et al., 
2004a). 
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In most cases phytoalexins and phytoalexin analogs were metabolized by S. 
sclerotiorum to their respective N-glucosides (Pedras and Ahiahonu, 2005). However, 
metabolism of N-protected indole analogs, 1-methoxybrassinin (4) and methyl 1-
methoxytryptamine dithiocarbamate (55) by S. sclerotiorum led to O-glucosylated 
metabolites (54, 56) (Pedras et al., 2004a) as shown in Scheme 1.4. 
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Scheme 1.4 Detoxification of methoxybrassinin (4) and methyl 1-methoxytryptamine 
dithiocarbamate (55) by Sclerotinia sclerotiorum (Pedras et al., 2004a). 
 
Metabolism of methyl 1-methyltryptamine dithiocarbamate (57) by S. 
sclerotiorum provided an oxidation product in addition to O-glucosylated product, as 
shown in Scheme 1.5. 
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Scheme 1.5 Detoxification of methyl 1-methyl tryptamine dithiocarbamate (57) by 
Sclerotinia sclerotiorum (Pedras et al., 2004a; Pedras and Ahiahonu, 2005). 
 
Metabolism of S-methyl-2-naphthylmethyl dithiocarbamate (61) by S. 
sclerotiorum yielded methyl 5-(O-β-D-glucopyranosyl)-2-naphthylmethyl 
dithiocarbamate (62) as shown in Scheme 1.6. However, methyl 1-naphthylmethyl 
dithiocarbamate was transformed to several undetermined metabolites (Pedras et al., 
2004a). 
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Scheme 1.6 Detoxification of methyl 2-naphthylmethyl dithiocarbamate (61) by 
Sclerotinia sclerotiorum (Pedras and Ahiahonu, 2005; Pedras et al., 2004a). 
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Previous biotransformation studies of p-substituted benzyl dithiocarbamate (63) 
in cultures of L. maculans showed that the dithiocarbamate moiety was transformed to 
the carboxylic acid group (p-toluic acid, 64) along with a minor metabolite N(p-
carboxybenzyl) dithiocarbamate (65) (Pedras et al., 1992), as shown in the following 
scheme 1.7. 
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Scheme 1.7 Detoxification of methyl N(p-methylbenzyl) dithiocarbamate (63) by 
Leptosphaeria maculans (Pedras et al., 1992). 
 
1.2.2.2  Brassilexin and related compounds 
Metabolism of brassilexin (21) by L. maculans produced 3-formylindolyl-2-
sulphonic acid (67) via 3-(amino)methyleneindoline-2-thione (66) (Pedras and Suchy, 
2005; Pedras, 2008). Brassilexin (21) was metabolized to 1-β-D-
glucopyranosylbrassilexin (68) by S. sclerotiorum. In addition, the phytoalexin 
brassicanal A (7) was formed via 3-(amino)methyleneindoline-2-thione (66) in the 
culture, as a minor metabolite after incubation with brassilexin (21) (Pedras and Hossain, 
2006). 
 
63 64 65 
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Scheme 1.8 Detoxification of brassilexin (21) by Leptosphaeria maculans and 
Sclerotinia sclerotiorum (Pedras, 2008). 
The substrate specificity of the enzyme involved in the detoxification of 
naturally occurring brassilexin (21) was investigated by incubation of 1-
methylbrassilexin (69) in S. sclerotiorum. Synthetic methylbrassilexin (69) was 
metabolized to 1-methyl-(oxy-O-β-D-glucopyranosyl)brassilexin (71) in the culture of S. 
sclerotiorum in about four days incubation period as shown in Scheme 1.9 (Pedras and 
Hossain, 2006). The rate of transformation in this case was slower than the 
transformation of naturally occurring brassilexin (21) and sinalexin (22). However, 
methylbrassilexin (69) was converted to enamine, 3-aminomethylene-1-methylindoline-
2-thione (70) in cultures of L. maculans (Pedras and Suchy, 2005). 
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Scheme 1.9 Detoxification of methylbrassilexin (69) by Leptosphaeria maculans and 
Sclerotinia sclerotiorum (Pedras, 2008; Pedras and Hossain, 2006). 
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1.2.2.3  Camalexin and related compounds 
Camalexin (24) was found stable in the fungal cultures of L. maculans and A. 
brassicae (Pedras and Khan, 1998; Pedras, 2004). Camalexin (24) was detoxified by R. 
solani via 5-hydroxycamalexin (72) to 5-hydroxyindole-3-carbonitrile (74) and 5-
hydroxy-2-formamidophenyl-2´-thiazolylketone (73) (Scheme 1.10) (Pedras, 2004; 
Pedras and Ahiahonu, 2005; Pedras and Khan, 2000; Pedras and Liu, 2004). 
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Scheme 1.10  Detoxification of camalexin (24) by Rhizoctonia solani, Leptospaeria 
maculans and Alternaria brassicae (Pedras and Liu, 2004; Pedras, 2004). 
 
Camalexin was biotransformed by S. sclerotiorum via 6-hydroxycamalexin (75) 
instead of 5-hydroxycamalexin (72) to 6-oxy-(O-β-D-glucopyranosyl)camalexin 
(Scheme 1.11) (Pedras and Ahiahonu, 2005; 2002). 
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Scheme 1.11  Detoxification of camalexin (24) by Sclerotinia sclerotiorum (Pedras et 
al., 2004a; Pedras and Ahiahonu, 2005; 2002). 
 
The selectivity and specificity of detoxifying enzymes of the stem rot fungus S. 
sclerotiorum were investigated by blocking the C-6 position of camalexin with -F and -
OCH3
O
HO OH
OHHO
N
H
S N
F N
S N
F
S. sclerotiorum
 substituents, as shown in Schemes 1.12 and 1.13. It was reported that 6-
fluorocamalexin (77) was transformed to 6-fluoro-(1-β-D-glucopyranosyl)camalexin 
(78) (Pedras and Ahiahonu, 2005; 2002). 
 
Scheme 1.12  Detoxification of 6-fluorocamalexin (77) by Sclerotinia sclerotiorum 
(Pedras and Ahiahonu, 2005; 2002, Pedras et al., 2004a). 
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6-Methoxycamalexin (79) was detoxified by S. sclerotiorum via two pathways: 
i) major pathway and ii) minor pathway. In the major pathway detoxification was 
accomplished via 6-hydroxycamalexin (75) to 6-oxy-(O-β-D-glucopyranosyl)camalexin 
(76) (Pedras and Ahiahonu, 2005; 2002). Methoxycamalexin (79) was partly converted 
to N-glucosylated product, 6-methoxy-(1-β-D-glucopyranosyl)camalexin (80) via a 
minor pathway (Pedras and Ahiahonu, 2005; 2002). 
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Scheme 1.13  Detoxification of 6-methoxycamalexin (79) by Sclerotinia sclerotiorum: 
i) major metabolite, ii) minor metabolite (Pedras and Ahiahonu, 2005; 2002). 
 
6-Fluoro-1-methylcamalexin (81) was metabolized by S. sclerotiorum to 
metabolites 6-fluoro-1-methyl-(O-β-D-glucopyranosyl)camalexin (82) and 6-fluoro-1-
methyl-indole-3-carbonitrile (83) (Pedras and Ahiahonu, 2005; 2002), at a slower rate 
than that observed for camalexin. 
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Scheme 1.14  Detoxification of 6-fluoro-1-methylcamalexin (81) by Sclerotinia 
sclerotiorum (Pedras and Ahiahonu, 2005; 2002). 
 
The detoxifying enzyme specificity of R. solani was investigated by using the 
camalexin analogs 5-fluorocamalexin (84) and 5-methylcamalexin (88). As shown in 
Scheme 1.15, 5-fluorocamalexin was detoxified by R. solani producing the metabolites 
2-(5-fluoro-3-indolyl)-oxazoline (85), 5-fluoroindole-3-carboxamide (86) and 5-
fluoroindole-3-carbonitrile (87) (Pedras and Liu, 2004). 
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Scheme 1.15  Detoxification of 5-fluorocamalexin (84) by Rhizoctonia solani (Pedras 
and Liu, 2004; Pedras and Ahiahonu, 2005). 
 
5-Methylcamalexin (88) was detoxified by R. solani producing the major 
metabolite, 5-(hydroxymethyl)camalexin (89) (Scheme 1.16). The minor metabolites 
identified were 2-(5-mehtyl-3-indolyl)-oxazoline (90) and 5-methylindole-3-
carboxamide (91) (Pedras and Liu, 2004). 
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Scheme 1.16  Detoxification of 5-methylcamalexin (88) by Rhizoctonia solani (Pedras 
and Liu, 2004; Pedras and Ahiahonu, 2005). 
 
1-Methylcamalexin (25), a phytoalexin from Capsella bursa-pastoris was 
metabolized by R. solani to 2-(1-mehtyl-3-indolyl)-oxazoline (92), 1-methylindole-3-
carboxamide (93) and 1-methylindole-3-carbonitrile (94) (Pedras and Liu, 2004). 
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Scheme 1.17  Detoxification of methylcamalexin (25) by Rhizoctonia solani (Pedras 
and Liu, 2004; Pedras and Ahiahonu, 2005). 
In my research project the biotransformations of the crucifer phytoalexins 
brassinin, brassilexin and camalexin were investigated using A. brassicicola. 
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1.3 Alternaria brassicicola  
Alternaria brassicicola is a necrotrophic fungus which causes blackspot disease 
in Brassica species (Brassica napus L. ssp. oleifera Metzg.). Scientific classification of 
Alternaria brassicicola (Schwein.) Wiltshire – Kingdom: Fungi; Phylum: Ascomycota; 
Class: Dothideomycetes; Subclass: Pleosporomycetidae; Order: Pleosporales; Family: 
Pleosporaceae; Genus: Alternaria; Species: A. brassicicola. This fungus exists almost 
everywhere – air, water and soil. Distribution: Cosmopolitan; Substrate: Leaves; Host: 
Brassicaceae; Disease Symptom:  Dark brown to black circular leaf spots. 
 
1.3.1 Pathogen significance: Blackspot disease 
A. brassicicola is a destructive fungal pathogen that produces a complex 
mixture of toxic secondary metabolites. A. brassicicola causes severe yield losses in 
crops such as canola, mustard or rape with 20-50% yield reductions in infected fields 
(Rotem, 1994; Huang and Chung, 1993). Three Alternaria species namely i) Alternaria 
brassicae, ii) Alternaria brassicicola and iii) Alternaria raphani (Alternaria japonica) 
are responsible for blackspot disease (Verma and Saharan, 1994). A. brassicicola infects 
not only leaves but also other parts of the plant including seeds, pods and stems (Rotem, 
1994). The necrotrophic nature of A. brassicicola is responsible for extensive damage to 
the plants. Disease propagation takes place from infected seeds to seedlings. The 
relationship between Brassica seeds internally infected by A. brassicicola and diseased 
seedlings was studied in England (Maude and Humpherson-Jones, 1980). This study 
showed that above 80% of commercial seeds were contaminated with A. brassicicola 
between 1976 and 1978. Insects also serve as transmission vectors for A. brassicicola 
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(Rotem, 1994). A. brassicicola spores kept in the leaf litter sporulate in the following 
season and initiate new infections (Humpherson-Jones and Maude, 1982). Dissemination 
of the disease during growing season is caused by rain and wind dislodged spores as 
well. Optimal conditions for sporulation and infection require the average period of 13 
hours and a temperature range of 18 ˚ C to 30 ˚ C (Humpherson-Jones and Phelps, 1989, 
Rotem, 1994). Continuous moisture for 24 hours or longer practically guarantees 
infection (Rangel, 1945; Rotem, 1994). Relative humidity of 91.5% (at 20 ˚C) or higher 
produces large numbers of mature spores in 24 hours (Humpherson-Jones and Phelps, 
1989). Thus, the presence of moisture in the form of free water or high relative humidity 
(at least 95%) is a requirement for germination (Degenhardt et al., 1982). Due to 
inadequate moisture, A. brassicicola rarely occurs in rapeseed on the cool prairies of 
Saskatchewan, Canada (Degenhardt et al., 1982, Rotem, 1994). 
Blackspot disease can be controlled by a combination of chemical, biological 
and physical treatments. Chemical control includes use of fungicides in the infected 
fields. However, it poses great problem to the environment indicating the importance of 
other alternatives. Seed treatment with hot water is an effective method for controlling 
spores on seed coat, thus reducing the chance of seed-borne infection. However, hot 
water treatment depresses germination. Crop rotation with non-crucifer crops will help 
controlling the disease. Fields that are replanted soon after harvest have highest chances 
of a large amount of inoculum (Humpherson-Jones, 1989). Cultivars of Brassica species 
resistant to blackspot fungus can be used to combat disease epidemics (Howard et al., 
1994; Verma and Saharan, 1994).  
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1.3.2 Secondary metabolites 
The complete set of chemical reactions that occur in all living organisms for 
their growth, development and reproduction are known as primary metabolism. The 
essential chemical compounds such as sugars, amino acids, common fatty acids and 
nucleotides are synthesized by primary metabolism and are called primary metabolites. 
There exists another type of metabolism by which compounds of secondary utilities are 
produced. The production of such type of metabolites is initiated during particular stages 
of growth and development or during periods of stress, which include nutritional 
limitations and microbial attack (Mann, 1987). These compounds are known as 
secondary metabolites. Primary requirements of life for living organisms are maintained 
by primary metabolism whereas secondary metabolism produces compounds for 
secondary requirements such as ecological fitness, species selection, interspecies 
competition, mating response and defense against pathogens and predators.  
The interaction between plant and pathogen is mediated partially by the 
production of secondary metabolites such as phytoalexins from plants and phytotoxins 
from fungi (Pedras et al., 2001). A. brassicicola produces a variety of secondary 
metabolites upon interaction with different species of crucifer (Otani et al., 1998). As 
well, crucifer plants utilize secondary metabolites for fighting against pathogens and 
other survival challenges. 
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1.3.2.1  Metabolites of Alternaria brassicicola 
Phytopathogenic fungi produce a broad spectrum of secondary metabolites in 
culture and in the host. The isolation and identification of metabolites from culture 
filtrates of A. brassicicola yielded no phytotoxins. It was reported that A. brassicicola 
released proteins as well as cytokinins in vivo and in vitro (Suri and Mandahar, 1984; 
Otani et al., 1998). In 1969 Lidenfelser and Ciegler identified a secondary metabolite by 
antibiotic disc assay against Bacillus subtilis using the antibiotic complex obtained from 
A. brassicicola (Lidenfelser et al., 1969). The trivial name brassicicolin A was assigned 
to this antibiotic. Later in 1988 Gloer and co-workers isolated this compound from the 
culture of A. brassicicola and the structure of this compound was determined (Gloer et 
al., 1988). Brassicicolin A (95) was reported as naturally occurring novel isocyanide 
antibiotic from A. brassicicola, but its phytotoxic activity has not been evaluated. 
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Figure 1.3 Chemical structure of brassicicolin A (95) 
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Depudecin (96), an antitumor agent containing two epoxide groups was isolated 
from the culture broth of A. brassicicola (Matsumoto et al., 1992). The compound was 
also found to be a histone deacetylase inhibitor (Kwon et al, 2003). 
O O OH
H OH
Depudecin
H
 
Figure 1.4 Chemical structure of depudecin (96) 
Fusicoccin (97) was first isolated from the culture filtrate of the 
phytopathogenic fungus Fussicoccum amygdali Del. (Ballio et al., 1964). Similar 
structural feature also exists in cotylenol (98), which was isolated from the fungal 
culture of Cladosporium spp. (Sassa et al., 1972). 
OCH3
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Figure 1.5 Chemical structures of fusicoccin (97) and cotylenol (98). 
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Six diterpenoid compounds were isolated from the culture filtrates of A. 
brassicicola possessing structural features similar to fusicoccin and cotylenol. These 
compounds were named as brassicicene A-F (99, 100, 101, 102, 103, 104) by 
MacKinnon and coworkers (MacKinnon et al., 1999). 
O
HO
OCH3
Brassicicene A Brassicicene B Brassicicene C
OH
HOHO
OCH3
HO
O
H H
OCH3
HO
HO
Brassicicene D
HO
O
HO
HO
OCH3
Brassicicene E
O
OAc
HO
HO
OCH3
Brassicicene F
O
H OH
OCH3
HO
HO
 
Figure 1.6  Chemical structures of brassicicene A-F (99, 100, 101, 102, 103, 104). 
 
1.3.2.2  Interaction with crucifers 
The chemical interaction of A. brassicicola with crucifers results in the 
production of secondary metabolites by both organisms. The phytoalexin camalexin (24) 
99 100 
101 
102 103 104 
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was detected in Arabidopsis thaliana as a defense response to pathogens (Tsuji et al., 
1992; Glazebrook and Ausubel, 1994). The wild type A. thaliana (Columbia) inoculated 
with A. brassicicola produced a stronger camalexin (24) response than the phytoalexin-
deficient PAD3-1 mutants (Thomma et al., 1999). The enhanced susceptibility of PAD3-
1 mutants in comparison to the wild type species of A. thaliana against A. brassicicola 
was attributed to a deficiency of camalexin production (Glawischnig, 2007). PAD3-1 
mutants are defective in camalexin synthesis that causes increased susceptibility to 
infection (Thomma et al., 1999). The PAD3 (PhytoAlexin Deficient 3) gene is the key 
determinant in the defense against A. brassicicola (Glawischnig, 2007; Thomma et al., 
1999). Studies suggested that PAD3-1 mutations not only changed the accumulation of 
camalexin (24) but also many defense related metabolites in response to the challenge 
against A. brassicicola (Narusaka et al., 2003). 
Crucifers integrate multiple responses including production of glucosinolates, in 
response to the invasion of A. brassicicola (Halkier and Gershenzon, 2006; Glawischnig, 
2007). The crucifers that are able to synthesize phytoalexins faster will be able to control 
the disease at the early stages. Thus, this group of plants will be resistant to the 
pathogen. If the fungus gets the advantage of spreading, the species will be disease 
sensitive. A. brassicicola produced phytotoxic fluids when incubated with different 
species of crucifer leaves (Otani et al., 1998). The spore germination fluid (SGF) as well 
as methanol extracts of culture filtrates of A. brassicicola tested for toxicity developed 
necrotic lesions on the leaves of infected crucifers (Otani et al., 1998; McDonald and 
Ingram, 1986; Oka et al., 2005). Culture filtrates of A. brassicicola were also found toxic 
to secondary embryoids of Brassica napus ssp. Oleifera (Metzg.), winter oilseed rape 
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(McDonald and Ingram, 1986). In their study, the methanol fraction of filtrates resulted 
in 90% death of the embryoids. Detached leaf tests using methanol extracts displayed 
chlorosis and necrosis, similar to that caused by the pathogen. Partially purified culture 
filtrates of A. brassicicola inhibited pollen germination of B. napus (Hodgkin and 
McDonald, 1986). Literature studies clearly indicated that extracts of A. brassicicola 
inhibited all stages of crucifer growth and development. 
 
1.4 Summary and conclusion 
Plants as sessile organisms are always exposed to a myriad of microbial and 
fungal invaders. Due to fungal invasion, the production of crucifer plants such as 
broccoli (B. oleracea var. botrytis), cabbage (B. oleracea var. capitata), cauliflower (B. 
oleracea var. italica), mustard (B. juncea) and canola is severely affected. A. 
brassicicola produces a complex blend of metabolites some of which are toxic to 
crucifer plants. In response, crucifer crops produce induced chemical defenses against A. 
brassicicola. Both organisms synthesize detoxifying enzymes to degrade each other’s 
chemical weapons. Isolation of detoxifying enzymes and detoxification metabolites will 
allow us to get a better understanding about pathogen invasion, host defense and 
virulence. Thus my research project was focused on the metabolism of crucifer 
phytoalexins by the phytopathogenic fungus A. brassicicola. In this introductory chapter 
I have summarized some of the relevant work published using A. brassicicola as well as 
biotransformation of crucifer phytoalexins by different fungi. 
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CHAPTER 2: RESULTS AND DISCUSSION 
2.1 Syntheses of phytoalexins 
For metabolism and biological activity studies, relatively large quantities of 
phytoalexins are necessary. Since it is difficult and time consuming to isolate larger 
quantities of these metabolites from plants, sufficient quantities required for the study of 
biotransformation and antifungal activity can be obtained through syntheses. There are 
several methods for the synthesis of each phytoalexin (Pedras et al., 2007a). For 
instance, three methods are known for brassinin synthesis. Phytoalexins used for this 
study were synthesized and characterized on the basis of spectroscopic analyses and 
comparison with authentic samples.  
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2.1.1 Synthesis of brassinin (2) 
Brassinin (2) was synthesized starting from indole-3-carboxaldehyde (42) in a 
four step process (Pedras et al, 1992), as shown in Scheme 2.1 
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Scheme 2.1  Synthesis of brassinin (2). Reagents and conditions: (i) NH2OH.HCl, 
Na2CO3, EtOH, 2 h, reflux, 60°C, 90%; (ii) NaBH4, NiCl2.6H2O, MeOH, rt, 50%; (iii) 
Pyridine, Et3N, CS2, 0°C; (iv) MeI, 0°C, 55%;(v) Pyridine, Ac2
105 
O, 1 h, 0°C, 60%. 
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2 
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2.1.2 Synthesis of brassilexin (21) 
Brassilexin was synthesized through Vilsmeier formylation of indoline-2-thione 
in a two-pot reaction starting from indoline-2-one (Pedras and Jha, 2005), as shown in 
Scheme 2.2. 
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Scheme 2. 2  Synthesis of brassilexin (21). Reagents and conditions: (i) P4S10, 
NaHCO3, THF, 81%; (ii) POCl3, DMF; (iii) NH4OH; (iv) I2
2.1.3 Synthesis of camalexin (24) 
, Pyridine, 52%. 
 
Synthesis of camalexin was performed following a published procedure (Ayer 
et al., 1992), as shown in Scheme 2.3 
N
H
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NS
 
Scheme 2. 3  Synthesis of camalexin (24). Reagents and conditions: (i) Mg, CH3I, 
Et2
106 
O; (ii) Benzene, 2-bromothiazole, 90 °C, 29%. 
107 
24 108 
21 66 
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2.2 Biotransformation of phytoalexins by Alternaria brassicicola 
2.2.1 Biotransformation of brassinin  
Brassinin (2) was synthesized as described in the experimental (Pedras et al, 
1992) and its biotransformation in liquid cultures of A. brassicicola was studied over a 
period of time as detailed in the experimental section. Samples from liquid cultures of A. 
brassicicola incubated with brassinin (2, 0.1 mM) were collected at 0 h and at different 
time intervals and extracted with EtOAc (2 × 10 mL). The organic extracts were 
concentrated under reduced pressure and the residues were dissolved in CH3CN (1mL) 
for HPLC analysis (Grad Screen method). Comparison of HPLC chromatograms of 
extracts of fungal cultures and control incubated with brassinin (2, 0.1 mM) indicated the 
emergence of a new metabolite and concomitant disappearance of brassinin (2) (Figure 
2.1). 
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Figure 2.1 Chromatograms (Grad Screen method) of extracts of liquid cultures of 
Alternaria brassicicola in minimal media (fungal culture) and only minimal media 
(control) incubated with brassinin (2, 0.1 mM) for different time intervals (0 h, 24 h and 
48 h).  
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It was observed that brassinin (2) was completely metabolized in fungal 
cultures to a major product (tR = 4.9 min) within 48 hours. The structure of this 
metabolite was established by analyses of its spectroscopic data and synthesis as follows. 
Comparison of 1H NMR spectra with that of brassinin (2) as well as with synthetic Nb-
acetyl-3-indolylmethylamine (46) (tR = 4.9 min) indicated the presence of protons due to 
an indole moiety at δ 7.65 (d, J=8 Hz, 1H), 7.40 (d, J=8 Hz, 1H), 7.17 (m, 2H), two 
methylene protons at δ 4.62 (d, J=5 Hz, 2H) and a singlet at δ 2.00 (s, 3H). The 
molecular formula of this metabolite (C11H12N2O) was determined by HRMS-ESI (m/z 
found 188.0949 M+
N
H
NH2
N
H
H
N CH3
O
N
H
H
N SCH3
S
, calc. 188.0947). Interestingly this metabolite was formed via 
indole-3-methylamine (45) intermediate (Scheme 2.4) similar to previous findings of 
brassinin biotransformation by L. maculans (Pedras et al., 2007d; Pedras and Taylor, 
1993).  
 
Scheme 2. 4  Biotransformation of brassinin (2) via amine (45) in fungal cultures of 
Alternaria brassicicola. 
 
 
 
2 45 
46 
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The formation of indole-3-methylamine (45) intermediate was determined by 
HPLC analysis (AMINE2 method) of basic extracts of fungal cultures incubated with 
brassinin (2, 0.1 mM). The appearance of indole-3-methylamine (tR = 6.4 min) in the 
chromatogram of basic extracts established that biotransformation of brassinin to Nb-
acetyl-3-indolylmethylamine (46) occurred via indole-3-methylamine (45) intermediate. 
The retention time (tR = 6.4 min) matches with standard amine. The presence of indole-
3-methylamine (45) was also confirmed by comparison of 1H NMR data of the basic 
extracts with spectroscopic data of an authentic amine sample. 
 
 
Figure 2.2 Chromatograms of both basic and neutral extracts of cultures of 
Alternaria brassicicola incubated with brassinin (2, 0.1 mM) for a period of 8 h.  
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The brassinin (2) biotransformation and formation of Nb-acetyl-3-
indolylmethylamine (46) curves as a function of time are depicted in Figure 2.3 
 
Figure 2.3 Curves for biotransformation of brassinin (2, 0.1 mM) and formation of 
Nb
Biotransformation of brassinin by A. brassicicola occurred in the side chain 
similar to the phytopathogenic fungi L. maculans and L. biglobosa (Pedras and Okanga, 
1998, 2000; Pedras and Ahiahonu, 2005). However, contrary to L. maculans and L. 
biglobosa, indole-3-carboxylic acid (43) was not detected as final detoxification product. 
It was shown from antifungal activity assay that the metabolite was a detoxification 
-acetyl-3-indolylmethylamine (46) in cultures of Alternaria brassicicola. 
Concentrations were calculated using calibration curves; each point is the average of 
experiment conducted in triplicate ± standard deviations. 
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product. Previous work showed that S. sclerotiorum yielded N-glucosylated metabolite 
rather than side chain modification of brassinin as shown in Scheme 1.1 (Pedras and 
Ahiahonu, 2005; Pedras et al., 2007d).  
 
2.2.1.1  Biotransformation of indole-3-methylamine  
Time-course experiments were conducted to confirm the transformation of 
indole-3-methylamine (45) to Nb-acetyl-3-indolylmethylamine (46) in cultures of A. 
brassicicola. Indole-3-methylamine (45) was synthesized as described in the 
experimental and incubated with cultures of A. brassicicola at 0.1 mM, as detailed in the 
experimental section. Samples from liquid cultures were collected at 0 h and at different 
time intervals and extracted with EtOAc (2 × 10 mL). The organic extracts were 
concentrated under reduced pressure and the residue was dissolved in CH3CN (1 mL) 
for HPLC analysis (Grad Screen method). The transformation of indole-3-methylamine 
(45) to Nb-acetyl-3-indolylmethylamine (46) was determined from the chromatograms of 
neutral extracts. The basic extracts were analyzed by HPLC (AMINE2 method) as 
detailed in the experimental section.  
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The curve for formation of the metabolic product, Nb-acetyl-3-
indolylmethylamine (46) is shown in Figure 2.4 
 
Figure 2.4 Curve for biotransformation of indole-3-methylamine (45, 0.1 mM) to 
Nb-acetyl-3-indolylmethylamine (46) in cultures of Alternaria brassicicola. 
Concentrations were calculated using calibration curves; each point is the average of 
concentrations from a single experiment conducted in triplicate ± standard deviations. 
 
Conversion of indole-3-methylamine (45) by A. brassicicola to Nb
 
-acetyl-3-
indolylmethylamine (46) confirmed that bioconversion of brassinin (2) takes place via 
indole-3-methylamine (45), as shown in Scheme 2.4. The formation of the detoxification 
product by L. biglobosa also occurred via indole-3-methylamine (45) as shown in 
Scheme 1.1 (Pedras and Ahiahonu, 2005; Pedras et al., 2007d). 
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2.2.1.2  Biotransformation of Nb-acetyl-3-indolylmethylamine  
Nb-acetyl-3-indolylmethylamine (46) was synthesized as described in the 
experimental and its biotransformation in liquid cultures of A. brassicicola was studied 
over a period of several days. Solutions of Nb-acetyl-3-indolylmethylamine (46) in 
acetonitrile (200 µL) were added to fungal cultures and were incubated. Control cultures 
were incubated in parallel. Samples from liquid cultures of A. brassicicola and control 
cultures incubated with Nb-acetyl-3-indolylmethylamine (46, 0.1 mM) were collected at 
0 h and at different time intervals and extracted with EtOAc (2 × 10 mL). The organic 
extracts were concentrated under reduced pressure and the residues were dissolved in 
CH3CN (1 mL) for HPLC analysis (Grad Screen method). The basic extracts were 
analyzed by HPLC (AMINE2 method) as detailed in the experimental section. Nb-acetyl-
3-indolylmethylamine (46) seems to be stable in the cultures over a period of 10 days. 
Further metabolism of Nb-acetyl-3-indolylmethylamine (46) by A. brassicicola was not 
observed in the HPLC chromatograms of both neutral and basic broth extracts (Grad 
Screen method and AMINE2 method, respectively). In addition, the antifungal activity 
experiments supported that Nb-acetyl-3-indolylmethylamine (46) was a detoxification 
product of brassinin (2).  
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The graph for the time-course experiment of (46) is shown in Figure 2.5 
 
 
 
Figure 2.5 Curve for biotransformation of Nb-acetyl-3-indolylmethylamine (46, 0.1 
mM) in cultures of Alternaria brassicicola. Concentrations were calculated using 
calibration curves; each point is the average of concentrations from a single experiment 
conducted in triplicate ± standard deviations. 
 
Indole-3-carboxylic acid (43) was the final metabolite in the detoxification of 
brassinin (2) by L. maculans and L. biglobosa as shown in Scheme 1.1. However, Nb-
acetyl-3-indolylmethylamine (46) was the final product for the detoxification of 
brassinin (2) by A. brassicicola. It is likely that A. brassicicola transforms 46 to 
metabolites not extractable with organic solvents due to their higher solubility in water. 
  44 
2.2.2 Biotransformation of brassilexin  
Brassilexin (21) was synthesized as described in the experimental and its 
biotransformation in liquid cultures of A. brassicicola was studied over a period of time. 
Solutions of brassilexin in acetonitrile were added to fungal cultures and were incubated. 
Control cultures were incubated in parallel. Samples from liquid cultures of A. 
brassicicola and controls incubated with brassilexin (21, 0.1 mM) were collected at 0 h 
and at different time intervals and extracted with EtOAc (2 × 10 mL). The extracts were 
concentrated under reduced pressure and the residues were dissolved in CH3CN (1 mL) 
for HPLC analysis (Grad Screen method). Brassilexin (21) was stable in control medium 
over 5 days. Metabolism of brassilexin (21, 0.1 mM) by A. brassicicola was completed 
within 24 h. Comparison of HPLC chromatograms of extracts of fungal cultures and 
control cultures indicated the emergence of a major peak (tR = 7.2 min) with 
disappearance of brassilexin. The new peak (tR = 7.2 min) was due to a known 
compound, 3-(amino)methyleneindoline-2-thione  (66) formed by reduction of the 
isothiazole ring of brassilexin (21) (Pedras and Suchy, 2005) in the fungal culture. The 
metabolism of brassilexin (21) by A. brassicicola to 3-(amino)methyleneindoline-2-
thione (66) is shown in Scheme 2.5. 
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Scheme 2. 5  Biotransformation of brassilexin (21) in cultures of Alternaria 
brassicicola. 
21 66 
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3-(Amino)methyleneindoline-2-thione (66) was synthesized to corroborate its 
identity, as described in the experimental. Biotransformation of brassilexin (21, 0.1 mM) 
over a period of time in the cultures of A. brassicicola is shown in figure 2.6. 
 
Figure 2.6 Curve for biotransformation of brassilexin (21, 0.1 mM) in cultures of 
Alternaria brassicicola. Concentrations were calculated using calibration curves; each 
point is the average of concentrations from a single experiment conducted in triplicate ± 
standard deviations. 
 
The metabolite (66) is less stable and readily oxidized to form brassilexin (21). 
Synthetic 3-(amino)methyleneindoline-2-thione (66) was also unstable in silica column 
and in solvent solutions. Chromatographic separation did not afforded pure compound 
and thus a calibration curve for the determination of concentration of 3-
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(amino)methyleneindoline-2-thione (66) was not prepared. The curve for the formation 
of 3-(amino)methyleneindoline-2-thione (66) is shown in Figure 2.7 using mAU instead 
of concentrations. 
 
Figure 2.7 Curve for the formation of 3-(amino)methyleneindoline-2-thione (66) in 
the biotransformation of brassilexin (21, 0.1 mM) by Alternaria brassicicola. A 
calibration curve for concentration determination was not prepared; each point is the 
average of areas in mAU (milliabsorbance units) from a single experiment conducted in 
triplicate ± standard deviations. 
 
Detoxification of brassilexin (21) by A. brassicicola yielded 3-
(amino)methyleneindoline-2-thione (66) similar to L. maculans and S. sclerotiourum as 
shown in Scheme 1.8 (Pedras, 2008).  
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2.2.2.1  Biotransformation of 3-(amino)methyleneindoline-2-thione  
3-(Amino)methyleneindoline-2-thione (66) was synthesized as described in the 
experimental and its biotransformation in liquid cultures of A. brassicicola was studied 
over a period of time. Solutions of 3-(amino)methyleneindoline-2-thione (66) in 
acetonitrile were added to fungal cultures and were incubated. Control cultures were 
carried out in parallel. Samples from liquid cultures of A. brassicicola incubated with 3-
(amino)methyleneindoline-2-thione (66, 0.1 mM) and control cultures were collected at 
0 h and at different time intervals and extracted with EtOAc (2 × 10 mL). The extracts 
were concentrated under reduced pressure and the residues were dissolved in CH3CN for 
HPLC analysis (Grad Screen method). 3-(Amino)methyleneindoline-2-thione (66) was 
almost completely metabolized in the cultures of A. brassicicola within ca. 24 h. 
Synthetic enamine (66) used for feeding experiment was not pure and it contained 
brassilexin (21) as was determined by 1H NMR . The spectroscopic data presented in the 
experimental section was assigned due to the presence of units from multiple entities in 
the tautomeric mixture of 3-(amino)methyleneindoline-2-thione, 3-(amino)methylene-2-
thiol and 3-(methylimino)indole-2-thiol (Pedras and Okanga, 1998). The initial 
concentration for feeding was determined on the basis of the ratio of the area of protons 
from 1H NMR. The concentration of this compound (66) was initially increased in the 
culture due to the faster reduction of the isothiazole ring of brassilexin (21) than 
transformation of 66, and then decreased.  
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The result of time-course experiments of 3-(amino)methyleneindoline-2-thione 
(66) metabolized in fungal cultures is shown in Figure 2.8 
 
Figure 2.8 Curve for the biotransformation of 3-(amino)methyleneindoline-2-thione 
(66, 0.1 mM) in cultures of Alternaria brassicicola (in minimal media). The calibration 
curves for concentration determinations were not prepared due to instability of 3-
(amino)methyleneindoline-2-thione (66) in solvent systems as well as in silica; each 
point is the average of concentrations from a single experiment conducted in triplicate ± 
standard deviations. 
 
3-(Amino)methyleneindoline-2-thione (66) was not a stable product and the 
compound exists as mixture of tautomers (Pedras and Okanga, 1998). Thus my attempt 
to establish 3-(amino)methyleneindoline-2-thione (66) as detoxification product of 
brassilexin (21) was unsuccessful.  
  49 
2.2.3 Biotransformation of camalexin 
The phytoalexin camalexin (24) is a strong inhibitor of growth against A. 
brassicicola. Camalexin (24) was synthesized as described in the experimental and its 
metabolism in liquid cultures of A. brassicicola was studied over a period of several 
days. Solutions of camalexin in acetonitrile were added to fungal cultures and were 
incubated. Control cultures were carried out in parallel. Samples from liquid cultures of 
A. brassicicola and controls incubated with camalexin (24, 0.1 mM) were collected at 0 
h and at different time intervals and extracted with EtOAc. The extracts were 
concentrated under reduced pressure and the residues were dissolved in CH3CN for 
HPLC analysis (Grad Screen method). I was not able to detect or identify any 
metabolites from the extracts of fungal cultures incubated with camalexin (24, 0.1mM). 
The process of metabolism of camalexin (24) may be very slow or the quantity of 
metabolites formation may be negligible or very polar (more water soluble). Longer 
incubation period may lead to the identification of metabolites for camalexin (24) 
metabolism. However, camalexin (24) was not metabolized by L. maculans, A. brassicae 
and pathogenic bacteria (Pedras and Khan, 1998). The decrease in concentration of 
camalexin (24) with increasing time of incubation may also be due to the absorption of 
camalexin (24) by cell membranes of mycelia. After 10 days, all mycelia from the 
culture flasks were filtered, air-dried and extracted with methanol to recover camalexin 
potentially trapped in mycelia cells. The methanol extracts were concentrated under 
reduced pressure and the residue was dissolved in methanol for HPLC analysis (Grad 
Screen method). The recovery of camalexin was 24% from mycelial cells with respect to 
the initial amount; altogether ca. 66% camalexin (24) was recovered.  
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The curve for time-course experiments of camalexin (24) is shown in figure 2.9. 
 
Figure 2.9 Curve for biotransformation of camalexin (24, 0.1 mM) in cultures of 
Alternaria brassicicola. Concentrations were calculated using calibration curves; each 
point is the average of concentrations from a single experiment conducted in triplicate ± 
standard deviations. 
 
Camalexin (24) biotransformation is different from that reported for R. solani 
(Scheme 1.10) (Pedras, 2004). However, this fact was not completely established 
perhaps due to the slow metabolism of camalexin (24) by A. brassicicola. Camalexin 
(24) was also metabolized by S. sclerotiorum but not metabolized by L. maculans or A. 
brassicae (Pedras et al., 2004a; Pedras and Ahiahonu, 2005; 2002; Pedras and Liu, 
2004). 
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2.3 Antifungal activity 
Antifungal activity of phytoalexins can be determined by conducting different 
types of bioassay such as fungal radial growth assay using PDA or minimal media on 
wells of tissue culture plates or Petri dishes (Pedras and Jha, 2006), fungal spore 
germination on TLC plates (Pedras and Sorenson, 1998) and filter paper disc assay 
(Lazarevic et al., 2001). In my study, mycelial radial growth bioassay on PDA media 
was chosen for the determination of percent inhibition of growth. At all times fungal 
radial growth assay results were reproducible and each bioassay was carried out in 
triplicate, using at least three independent experiments. The final concentrations of assay 
compounds were 5.0 × 10-4 M, 2.0 × 10-4 M and 1.0 × 10-4
Table 2.1 Percentage of growth inhibition of Alternaria brassicicola incubated with 
phytoalexins (2, 21 and 24) and metabolites (45, 46, 66) after 72 h of incubation under 
constant light. 
 
 M in PDA media. The results 
of the antifungal activity using mycelial radial growth are summarized in the following 
Table 2.1. 
Name of assay compound Concentrations (M) % Inhibitiona 
Brassinin (2) 5.0 × 10 39±2 -4 
2.0 × 10 31±2 -4 
1.0 × 10 22±1 -4 
Indole-3-methylamine (45) 5.0 × 10 16±1 -4 
2.0 × 10 5±1 -4 
1.0 × 10 N.I.  -4 
Nb-acetyl-3-indolylmethylamine (46) 5.0 × 10 N.I. -4 
2.0 × 10 N.I. -4 
1.0 × 10 N.I. -4 
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Name of assay compound Concentrations (M) % Inhibitiona 
Brassilexin (21) 5.0 × 10 85±2 -4 
2.0 × 10 59±2 -4 
1.0 × 10 50±3 -4 
3-(Amino)methyleneindoline-2-thione 5.0 × 10b 
(66) 
92±3 -4 
2.0 × 10 59±1 -4 
1.0 × 10 47±1 -4 
Camalexin (24) 5.0 × 10 C.I. -4 
2.0 × 10 85±1 -4 
1.0 × 10 53±1 -4 
a [The percentage of inhibition was calculated using the formula: % inhibition = 100 – 
{(growth on amended/growth in control) × 100} ± standard deviation]; results are the 
means of at least three independent experiments; C.I., Complete Inhibition; N.I., No 
Inhibition. 
b Synthetic enamine was not obtained in pure form since the compound was not stable 
in silica as well as in solvent solutions. The purity of the compound may be the cause 
for high inhibition in bioassay results as expected with respect to brassilexin. 
 
2.4 Conclusion 
The antifungal activity and biotransformation of crucifer phytoalexins against 
A. brassicicola were investigated. The phytoalexins used for feeding and bioassay 
experiments were synthesized as detailed in the experimental. The purity of products 
was confirmed by spectroscopic analyses. The metabolism of brassinin (2) gave a known 
metabolite (46) which was isolated, characterized as well as synthesized for structural 
determination. Finally, the antifungal bioassay and feeding experiments confirmed that 
the transformation was a detoxification process. In addition, it is clear from this study 
that the putative intermediate in the transformation of brassinin (2) is an amine (45) 
similar to the metabolism occurring in other fungi (Pedras and Okanga, 2000).  
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The metabolism of brassilexin (21) gave a metabolite which was a known 
compound isolated earlier (Pedras and Suchy, 2005). This metabolite (66) was 
synthesized and used for both bioassay and feeding experiments to confirm the 
metabolism and detoxification process. The metabolism of brassilexin (21) was not in 
agreement with the expected trend of phytoalexin detoxification. The discrepancies in 
the result of bioactivity and metabolism can be attributed to the instability and 
unavailability of the detoxification product in the pure form for biotransformation.  
Camalexin metabolism was very slow and any metabolite from 
biotransformation of camalexin in the culture of A. brassicicola was not detected within 
10 days of incubation period. Antifungal activity showed that camalexin (24) was a 
strong growth inhibitor against A. brassicicola whereas brassinin (2) displayed lower 
inhibition than brassilexin and camalexin. The percent inhibition of growth against A. 
brassicicola caused by brassilexin (21, 0.5 mM) was 85, suggesting that brassilexin is a 
reasonable inhibitor. Kagan and co-workers reported that TLC bioassay results of 
camalexin showed poor inhibitory effect against A. brassicicola (Kagan et al., 2002). 
However, the mycelial radial growth bioassay in my study suggested that camalexin (24) 
is a strong inhibitor of A. brassicicola. Brassinin (2) metabolism was completed in the 
cultures of A. brassicicola over a period of 48 h. Brassilexin (21) was metabolized in 
cultures of A. brassicicola within ca. 24 h. I was not able to detect any metabolite from 
camalexin metabolism within 10 days incubation period which left the possibility of 
future work of the metabolism study for longer incubation periods.  
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CHAPTER 3: EXPERIMENTAL 
3.1 General methods 
All chemicals were purchased from Sigma-Aldrich Canada Ltd., Oakville, ON, 
Canada. All solvents were HPLC grade and used as such, except phosphorous 
oxychloride (POCl3), benzene and ether which were redistilled. Solvents used in 
syntheses were dried over the following drying agents prior to distillation and use: 
benzene over CaH2 and diethyl ether over sodium/benzophenone. 
Analytical Thin Layer Chromatography (TLC) was carried out on precoated 
silica gel TLC aluminum sheets (Merck, Kieselgel 60 F254, 5 × 2.5 cm × 0.2 mm). 
Compounds were visualized by exposure to UV (254 nm) after elution with a suitable 
solvent system. Finally plates were charred by dipping in a 5% aqueous (w/v) 
phosphomolybdic acid solution containing 1% (w/v) ceric sulphate and 4% (v/v) H2SO4, 
followed by heating on a hot plate. Preparative Thin Layer Chromatography (PTLC) was 
performed on silica gel glass plates (Merck, Kieselgel 60 F254, 20 × 20cm × 0.25 mm). 
Flash Column Chromatography (FCC) was carried out on silica gel (Merck, grade 60, 
and mesh size 230-400, 60 Å). 
HPLC analyses were carried out with Agilent 1100 series high performance 
liquid chromatographic systems equipped with a quaternary pump, automatic injector 
and diode array detector (wavelength range 190-600 nm), degasser and Eclipse XSB C-
18 columns (5 µm particle size, 150 x 4.6 mm diameter), equipped with an in-line filter. 
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The mobile phase consisted of a linear gradient of water and acetonitrile (75:25 to 25:75 
in 35 min to 0:100 in 5 min, Grad Screen method) and a flow rate of 1 mL/min. Samples 
for HPLC analysis were dissolved in CH3CN (ca. 0.2 mg/mL to 0.5 mg/mL) and filtered 
through a cotton plug. 
HPLC analysis for amine detection (AMINE2 method) was  carried out with an 
Agilent 1200 series high performance liquid chromatographic system equipped with 
quaternary pump, automatic injector and diode array detector (wavelength range 190-
600 nm), degasser and an Eclipse XDB-CN column (5 µm particle size, 150 × 4.6 mm 
diameter), equipped with an in-line filter. The mobile phase consisted of a linear gradient 
of 0.5% NH4OH in isopropanol and hexane (85:15 to 100:0 in 15 min and 0:100 to 85:15 
in 5 min, AMINE2 method) and a flow rate of 1 mL/min. Samples for HPLC analysis 
were prepared by dissolving in CH3CN (ca. 0.2 mg/mL to 0.5 mg/mL) and passing 
through a cotton plug. 
HPLC-MS-ESI analysis was carried out with an Agilent 1100 series HPLC 
system equipped with an autosampler, binary pump, degasser, and a diode array detector 
connected directly to a mass detector (Agilent G2440A MSD-Trap-XCT ion trap mass 
spectrometer) with an ESI source. Chromatographic separation was carried out at room 
temperature using an Eclipse XSB C-18 column (5 µm particle size, 150 x 4.6 mm 
diameter).The mobile phase consisted of a linear gradient of 0.2% formic acid in water 
(A) and 0.2% formic acid in acetonitrile (B) [75:25 to 25:75 (A:B) in 35 min and 0:100 
(A:B) in 5 min] and a flow rate of 1mL/min. Samples were prepared by dissolving in 
acetonitrile (ca 0.2 mg/mL to 0.5 mg/mL) and passing through a cotton plug. 
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NMR spectra were recorded on Bruker Avance 500 MHz spectrometesr. For 1H 
NMR (500 MHz), the chemical shifts (δ) are reported in parts per million (ppm) relative 
to TMS. The δ values were referenced to CHCl3 in CDCl3 at 7.27 ppm and CHD2CN in 
CD3CN at 1.94 ppm. Multiplicities are denoted by the following symbols: s = singlet, d 
= doublet, dd = doublet of doublets, m = multiplets and br = broad. Spin coupling 
constants (J values) are reported to the nearest 0.5 Hz. For 13
3.2 Syntheses of phytoalexins 
C NMR (125.8 MHz), δ 
values are referenced to CDCl3 (77.23 ppm) and CD3CN (118.69 ppm). 
Mass Spectra [high resolution (HR), electron impact (EI)] were obtained on a 
VG 70 SE mass spectrometer at electron beam energy of 70 eV using a solids probe. 
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Scheme 3.1 Synthesis of brassinin (2) 
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An aqueous solution of NH2OH.HCl (952 mg, 13.7 mmol) and Na2CO3 (803 
mg, 7.6 mmol) in water (14 mL) was added to a solution of indole-3-carboxaldehyde 
(42) (1.0 g, 6.9 mmol) in EtOH (30 mL). After stirring for 3 hours at 60 °C, EtOH was 
removed under reduced pressure and ice cold water was added to the residue. The 
resulting precipitate was filtered off and air dried to afford indole-3-carboxaldehyde 
oxime (105) (995 mg) in 90% yield (Pedras et al., 1992).  
Sodium borohydride (140 mg, 3.7 mmol) was added in small portions to a 
solution of indole-3-carboxaldehyde oxime (105) (200 mg, 1.25 mmol) and 
hexahydrated nickel chloride (298 mg, 1.25 mmol) in methanol (25 mL) with vigorous 
stirring. The reaction mixture was filtered off (under gravity filtration) after 15 minutes 
of stirring and the volume was reduced to approximately 1/3 under reduced pressure. 
The resulting mixture was diluted with water and basified with aqueous NH4OH (28%, 
pH 9). The basified solution was extracted using EtOAc (3 x 50 mL), the organic 
extracts were combined, dried over Na2SO4 and evaporated under reduced pressure to 
yield the crude amine. The crude product was purified by FCC eluting with CH2Cl2-
MeOH-NH4OH (80:20:1) to afford indole-3-methylamine (45) in 50% yield (Kutschy et 
al., 1998). 
Indole-3-methylamine (45):  
HPLC tR = 6.0 min (AMINE2 Method). 
1H NMR (500 MHz, CD3CN): δ 9.19 (br s, 1H), 7.61 (d, J=8 Hz, 1H), 7.38 (d, J=8 Hz, 
1H), 7.13 (m, 2H), 7.04 (dd, J=7.5, 7.5 Hz, 1H), 3.95 (s, 2H), 2.05 (s, 2H). 
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Carbon disulfide (70 µL, 1.5 mmol) was added to a solution of indole-3-
methylamine (45) (220 mg, 1.5 mmol) and triethylamine (217 µL, 3 mmol) in pyridine 
(2.3 mL) at 0˚C. After stirring for 20 minutes, CH 3I (93 µL, 1.5 mmol) was added and 
the resulting reaction mixture was stirred for an additional 1 hour. The reaction mixture 
was acidified with 1.5 M H2SO4 and extracted with Et2O (2 x 25 mL). The organic 
extracts were combined, dried over Na2SO4 and concentrated under reduced pressure 
using toluene. The residue was purified by FCC on silica gel eluting with EtOAc-hexane 
(40:60) to afford brassinin (2) which was finally crystallized from CH2Cl2, white crystals 
in 55% yield (Pedras et al., 1992).  
Brassinin (2): 
HPLC tR = 20.5 min (Grad Screen method). 
1H NMR (500 MHz, CD3CN): δ 9.25 (br s, 1H),  8.25 (br s, 1H), 7.63 (d, J=8 Hz, 1H), 
7.42 (d, J=8 Hz, 1H), 7.31 (d, J=2 Hz, 1H), 7.16 (dd, J=8, 8 Hz, 1H), 7.09 (dd, J=8, 8 
Hz, 1H), 5.04 (d, J=5 Hz, 2H), 2.55 (s, 3H). 
13
3.2.1.1  Synthesis of Nb-acetyl-3-indolylmethylamine (46)  
C NMR (125.8 MHz, CD3CN): δ 199.1 (s), 137.7 (s), 128.1 (s), 126.1 (s), 123.2 (d), 
120.7 (d), 119.8 (d), 120.7 (d), 112.9 (d), 111.8 (s), 43.5 (s), 18.5 (s). 
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Scheme 3.2 Synthesis of Nb-acetyl-3-indolylmethylamine (46) 
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  59 
 
To a solution of indole-3-methylamine (45) (29 mg, 0.2 mmol) in pyridine (500 
µL, 6.1 mmol) at 0˚C, Ac 2O (85 µL, 0.89 mmol) was added. The reaction mixture was 
stirred for an additional 1 hour at room temperature. Pyridine was removed by 
evaporating the solvent under reduced pressure using toluene. The crude product was 
purified by crystallization from hexane and CH2Cl2, white crystals (60%) of Nb-acetyl-3-
indolylmethylamine (46).  
Nb-acetyl-3-indolylmethylamine (46): 
HPLC tR = 4.9 min (Grad Screen method). 
1H NMR (500 MHz, CD3CCl3): δ 8.12 (br s, 1H), 7.65 (d, J=8 Hz, 1H), 7.40 (d, J=8 Hz, 
1H), 7.25 (m, 1H), 7.17 (m, 2H), 5.61(br s, 1H), 4.62 (d, J=5, 2H), 1.99 (s, 3H). 
13
3.2.2 Synthesis of brassilexin (21)  
C NMR (125.8 MHz, CD3CN) δC 170.7 (s), 137.9 (s), 128.0 (s), 124.8 (s), 123.0 (s), 
120.4 (s), 120.0 (s), 114.2 (s), 112.7 (s), 35.5 (s), 23.3 (s). 
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Scheme 3.3 Synthesis of brassilexin (21) 
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A mixture of 2-oxindole (500 mg, 3.75 mmol) and P2S5 (1.0 g, 2.25 mmol) in 
THF (25 mL) was stirred for 15 minutes at room temperature. Sodium bicarbonate (631 
mg, 7.5 mmol) was then added to the reaction mixture with stirring. The resulting 
solution was allowed to stir for 4 hours at room temperature and filtered (by gravity). 
The excess THF was removed by evaporation under reduced pressure. Ice-cold water 
was added to the residue with vigorous stirring to yield a light yellow product. The 
precipitate was filtered and air dried to get indoline-2-thione (107) (458 mg, 81%) 
(Kamila and Biehl, 2004). 
Indoline-2-thione (107) (200 mg, 1.3 mmol) was added to a mixture of freshly 
distilled POCl3 (250 µL, 2.6 mmol) in DMF (1.5 mL) at 45˚C with stirring. After 20 
minutes, the reaction mixture was placed on an ice bath to cool down to 0˚C. Aqueous 
NH4OH (28%, 15 mL) was added dropwise with constant stirring and the mixture was 
allowed to warm up to room temperature. The resulting solution was extracted with Et2O 
(3 x 30 mL) and the organic extracts were combined, dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was dissolved in pyridine (4 
mL) and I2 (160 mg, 0.63 mmol) was added to the reaction mixture. After one hour of 
stirring, the reaction mixture was acidified with 1.5 M H2SO4 and extracted with Et2O (2 
x 25 mL). The organic extracts were combined, dried over Na2SO4 and concentrated 
under reduced pressure. The crude product was purified by FCC on silica gel eluting 
with EtOAc-hexane (20:80) to afford brassilexin (21) in 52% yield (Pedras and Jha, 
2005). 
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Brassilexin (21): 
HPLC tR = 13.4 min (Grad Screen method). 
1H NMR (500 MHz, CD3CN): δ 9.85 (br s, 1H), 8.69 (s, 1H), 7.90 (d, J=8 Hz, 1H), 7.55 
(d, J=8 Hz, 1H), 7.32 (dd, J=8, 8 Hz, 1H), 7.22 (dd, J=8, 8 Hz, 1H). 
13
3.2.2.1  Synthesis of 3-(amino)methyleneindoline-2-thione (66) 
C NMR (125.8 MHz, CD3CN): δ 160.5 (s), 148. 9(s), 145.6 (s), 128.6 (s), 125.0 (s), 
121.8 (s), 121.3 (s), 121.1 (s), 113.4 (s). 
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Scheme 3.4 Synthesis of 3-(amino)methyleneindoline-2-thione (66) 
 
Indoline-2-thione (107) (50 mg, 0.33 mmol) was added to a mixture of freshly 
distilled POCl3 (64 µL, 0.7 mmol) in DMF (350 µL, 5.0 mmols) at 45˚ C with stirring. 
After 45 minutes, the reaction mixture was placed on an ice bath to cool down to 0˚C. 
Aqueous NH4OH (28%, 10 mL) was added dropwise with constant stirring (pH 11) and 
the temperature was brought to room temperature. The resulting solution was extracted 
with Et2O (2 x 20 mL) and the organic extracts were combined, dried over Na2SO4 and 
concentrated under reduced pressure. The crude product was purified by FCC on silica 
gel eluting with MeOH-CH2Cl2 (2:98) to afford 3-(amino)methyleneindoline-2-thione 
(66) (52%).  
66 107 
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3-(Amino)methyleneindoline-2-thione (66): 
HPLC tR = 7.2 min (Grad Screen method). 
1
3.2.3 Synthesis of camalexin (24)  
H NMR (500 MHz, CD3CN): δ 11.01 (br s, 1H), 9.8 (br s, 1H), 8.25 (dd, J=15, 8 Hz, 
1H), 7.46 (d, J=8 Hz, 1H), 7.31 (m, 1H), 7.07 (m, 3H). 
N
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Scheme 3.5 Synthesis of camalexin (24) 
 
Methyl iodide (295 µL, 4.75 mmol) was added slowly by injection at room 
temperature under argon atmosphere to magnesium turnings (77 mg, 3.2 mmol) in dry 
ether (15 mL). After all of the magnesium had reacted (disappeared), the ether was 
distilled off and dry benzene (7 mL) was added. A solution of indole (200 mg, 1.7 
mmol) in benzene (1 mL) was added to the solution of methyl magnesium iodide in 
benzene and stirred for 15 minutes after which 2-bromothiazole was added. After 
refluxing at 90 ºC for 24 h, the reaction mixture was cooled to room temperature and 
extracted with EtOAc (3 × 20 mL). The EtOAc extracts were combined, dried over 
Na2SO4 and concentrated under reduced pressure and the residue was separated by FCC 
on silica gel eluting with EtOAc-hexane (20:80) to afford camalexin (24) in 29% yield 
(Ayer et al., 1992). 
 
24 108 
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Camalexin (24): 
HPLC tR = 15.3 min (Grad Screen method). 
1H NMR (500 MHz, CD3CN): δ 9.78 (br s, 1H), 8.28 (d, J=6.5, 1H), 7.9 (s, 1H), 7.8 (s, 
1H), 7.55 (d, J=7 Hz, 1H), 7.37 (d, J=2 Hz, 1H), 7.28 (dd, J=7, 7 Hz, 2H). 
13
3.3 Biotransformations of phytoalexins by Alternaria brassicicola 
C NMR (125.8 MHz, CD3CN): δ 164.6 (s), 143. 9 (s), 138.0 (s), 127.0 (s), 125.9 (s), 
124.1 (s), 122.4 (d), 121.7 (s), 117.3 (s), 113.3 (s), 112.6 (d). 
 
3.3.1 Preparation of minimal media 
Solution 1 (100 mL) containing 31.2 g/L KNO3, 7.5 g/L K2HPO4, 7.5 g/L 
KH2PO4, 1.0 g/L NaCl and 2.8 g/L asparagine was added to  a solution of glucose (15.0 
g) in 700 mL of distilled water. Solution 3 (1 mL) containing 0.39 g/L ZnSO4.7H2O, 
0.08 g/L CuSO4.5H2O, 0.41 g/L MnSO4.4H2O, 0.018 g/L MoO3 (85%), 0.54 g/L ferric 
citrate and 0.38 g/L Na2B4O7.10H2O was added to it. The mixture was diluted up to 900 
mL using distilled water and autoclaved. Solution 2 (100 mL), containing 1.0 g/L CaCl2. 
7H2O and 5.0 g/L MgSO4.7H2O was prepared separately and autoclaved. After 
autoclaving, the two solutions were allowed to cool to room temperature before mixing 
them together. A sterile solution 4 (1 mL) containing 100 g/L of thiamine was finally 
added to prepare minimal media (Pedras et al., 1997). 
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3.3.2 Preparation of fungal cultures 
Alternaria brassicicola (ATCC 96866) spores were grown on potato dextrose 
agar (PDA) media in sterile polystyrene Petri dishes (100 × 15 mm). Petri dishes were 
then incubated under constant light at 22˚C ±1˚C. After eight days, spores were collected 
and stored at -20˚C. Erlenmeyer flasks (250 mL) containing 100 mL of minimal media 
were inoculated each time with eight-day old spores (106
3.3.3 Time-course experiments 
 spores/100 mL) and incubated 
on a shaker (@ 120 rpm) under constant light at a temperature of 22˚C ±1˚C for 24 
hours. 
Time-course experiments were carried out to determine minimum 
concentrations and optimum periods for the formation of metabolites in fungal cultures. 
Initial experiments suggested that the minimum concentrations for phytoalexin 
biotransformation at different incubation periods were 1.0 × 10-4 M. For conducting 
time-course experiment, phytoalexins dissolved in acetonitrile (200 µL) were added to 
the fungal cultures (final concentration, 1.0× 10-4 M) as well as to the flasks containing 
only minimal media (control media); only acetonitrile (200 µL) was added to one of the 
fungal culture flasks (control fungus). Samples were collected (10 mL) from the culture 
flasks at 0 h and at different time intervals and extracted with EtOH (2×10 mL). Organic 
extracts were concentrated under reduced pressure and the residue was dissolved in 1mL 
CH3CN for HPLC analysis. The aqueous layer was basified with NH4OH (28%, pH 9), 
extracted with 5% methanol in CH2Cl2, concentrated under reduced pressure and the 
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residue was dissolved in 1mL of CH3CN for HPLC analysis employing AMINE2 
method. 
3.4 Bioassays 
Six-well tissue culture plates were employed for bioassay studies and sterilized 
by UV light exposure (1 h) before introducing the assay medium. Solutions of 
phytoalexins and other compounds (final concentrations of 5.0 × 10-4 M, 2.0 × 10-4 M 
and 1.0 × 10-4 M) in CH3CN were added to warm PDA medium in a Falcon® tube. After 
mixing (vortex), PDA mixture was poured into wells. In control wells only solvent (1% 
CH3CN) with PDA medium (vortex mixing) were introduced. Eight-day old mycelial 
plugs of A. brassicicola were obtained by growing them on PDA at 22° ± 1°C under 
constant light in Petri dishes.  In each well, 4-mm PDA plugs of mycelium were placed 
on the center of the wells, upside down, and incubated at 22° ± 1°C under constant light 
for 72 h. Mycelial radial growth was monitored over the period and the percent 
inhibition of growth was calculated. Bioassay experiments were carried out in triplicate 
at least three independent experiments for each bioassay. 
 
  66 
CHAPTER 3: REFERENCES 
 
Ayer, W. A., Craw, P. A., Yu-ting M., Miao, S., 1992. Synthesis of camalexin and 
related phytoalexins. Tetrahedron, 48, 2919-2924. 
 
Ballio, A., Chain, E. B., De Leo, P., Erlanger, B. F., Mauri, M., Tonolo, A., 1964. 
Fussicoccin: A New Wilting Toxin produced by Fussicoccum amygdali Del. 
Nature, 203(4942), 297. 
 
Banerjee, T., DuHadaway, J. B., Gaspari, P. Sutanto-Ward, E., Munn, D. H., Mellor, A. 
L., Malachowski, W. P., Prendergast, G. C., Muller, A. J., 2008. A key invivo 
antitumor mechanism of action of natural product-based brassinins is inhibition 
of indole-2,3-dioxygenase. Oncogene, 27, 2851-2857. 
 
Baur, R., Stadler, E., Monde, K., Takasugi, M., 1998. Phytoalexins from Brassica 
(Cruciferae) as oviposition stimulants for the cabbage root fly, Delia radicum. 
Chemoecology, 8, 163-168. 
 
Brooks, C. J. W., Watson, D. G., 1991. Terpenoid phytoalexins. Natural Product 
Reports, 8, 367-389. 
 
Cruickshank, I. A. M., Perrin, D. R., 1960. Isolation of a phytoalexin from Pisum 
sativum L. Nature, 187, 799-800. 
 
Dahyia, J. S., Rimmer, S. R., 1998. Phytoalexin accumulation in tissues of Brassica 
napus inoculated with Leptosphaeria maculans. Phtytochemistry, 27, 3105-3107. 
 
Darvill, A. G., Albersheim, P., 1984. Phytoalexins and their elicitors-a defense against 
microbial infection in plants. Annual Review of Plant Physiology, 35, 243. 
 
  67 
Degenhardt, K. J., Petrie, G. A., Morrall, R. A. A., 1982. Effects of temperature on spore 
germination and infection of rapeseed by Alternaria brassicae, A. brassicicola, 
and A. raphani. Canadian Journal of  Plant Pathology, 4, 115-118. 
 
Devys, M., Barbier, M., Loiselet, I., Rouxel, T., Sarniguet, A., Kollmann, A., Bousquet, 
J. F., 1988. Brassilexin, a novel sulfur containing phytoalexin from Brassica 
juncea L. (Cruciferae). Tetrahedron Letters, 29(49), 6447-6448. 
 
Glawischnig, E., 2007. Molecules of interest camalexin. Phytochemistry, 68, 401-407. 
 
Glawischnig, E., Hansen, B. G., Olsen, C. E., Halkier, B. A., 2004. Camalexin is 
synthesized from indole-3-acetaldoxime, a key branching point between primary 
and secondary metabolism in Arabidopsis. Proceedings of the Natural Academy 
of Sciences, USA, 101, 8245-8250. 
 
Glazebrook, J., Ausubel, F. M., 1994. Isolation of phytoalexins deficient mutants of 
Arabidopsis thaliana and characterization of their interactions with bacterial 
pathogens. Proceeding of Natural Academy of Sciences, USA, 91, 8955-8959.  
 
Gloer, J. B., Poch, G. K., Short, D. M., McCloskey. D. V., 1988. Structure of 
Brassicicolin A: A novel Isocyanide Antibiotic from the Phylloplane Fungus 
Alternaria brassicicola. A Journal of Organic Chemistry, 53, 3758-3761. 
 
Halkier, B. A., Gershenzon, J., 2006. Biology and biochemistry of glucosinolates. 
Annual Review of Plant Biology, 57, 303-333. 
 
Hammerschmidt, R., Dann, E. K., 1999. The role of phytoalexins in plant protection. 
Novartis Foundation Symposium, 223, 175-190. 
 
Harborne, J. B., 1999. The comparative biochemistry of phytoalexin induction in plants. 
Biochemical Systematics and Ecology, 27, 335-367. 
  68 
 
Hodgkin, T., McDonald, V., 1986. The effect of phytotoxins from Alternaria 
brassicicola on  Brassica pollen. New Phytology, 104, 631-636.  
 
Howard, R. J., Garland, J. A., Seaman, W. L. Eds., 1994. Diseases and pests of vegetable 
crops in Canada. The Canadian Phytopathological Society and the Entomological 
Society of Canada: Ottawa, pp. 92-123. 
 
Huang, J. W. and Chung, W. C., 1993. Characteristics of cruciferous black spot 
pathogens, Alternaria brassicicola and A. brassicae. Plant Pathology Bulletin, 2, 
141- 148. 
 
Humpherson-Jones, F. M., 1989. Survival of Alternaria brassicae and Alternaria 
brassicicola on crop debris of oilseed rape and cabbage. Ann. appl. Biol. 115, 45-
50. 
 
Humpherson-Jones, F. M., Maude, R. B., 1982. Studies on the epidemiology of 
Alternaria brassicicola in Brassica oleracea seed production crops. Ann. appl. 
Biol., 100, 61-71. 
 
Humpherson-Jones, F. M., Phelps, K., 1989. Climatic factors influencing spore 
production in Alternaria brassicae and Alternaria brassicicola. Ann. appl. Biol., 
114, 449-458. 
 
Ingham, J. L., 1982. Phytoalexins from the Leguminosae. In: Bailey, J. A., Mansfield J. 
W. (eds) Phytoalexins, New York: John Wiley & Sons, pp. 21-80. 
 
Jadhav, S. J., Mazza, G., Salunkhe, D. K., 1991. Terpenoid phytoalexins in potatoes: a 
review. Food Chemistry, 41, 195-217. 
 
  69 
Johnson, I. T., Williamson, G, Musk, S. R. R., 1995.Anticarcinogenic factors in plant 
foods. A new class of nutrients? Nutrition Research Reviews. 7, 175-204. 
 
Kagan, I A. and Hammerschmidt, R., 2002. Arabidopsis Ecotype variability in 
camalexin production and reaction to infection by Alternaria brassicicola. 
Journal of Chemical Ecology, 28, 2121-2140. 
 
Kamila, S.; Biehl, E.; 2004. Preparation of benzothiopyrano[2,3-b]indoles by the 
reaction of 1,3-dihydroindole-2-thiones with certain dienophiles. Heterocycles, 
63, 2785-2795. 
 
Kutschy, P., Dzurilla, M., Takasugi, M.,Torok, M., Achbergerova, I., Homzova, R. and 
Racova, M., 1998. New syntheses of indole phytoalexins and related compounds. 
Tetrahedron, 54, 3549-3566. 
 
Kwon, H. J., Kim, J. H., Kim, M., Lee J. K., Hwang, W. S., Kim, D. Y., 2003. Anti-
parasitic activity of depudecin on Neospora caninum via the inhibition of histone 
deacetylase. Veterinary Parasitology, 112, 269-276. 
 
Lazarevic, M., Dimova, V., Gabor, D. M., Kakurinov, V., Ragenovic, K. C., 2001. 
Synthesis of some N1-aryl/heteroarylaminomethyl/ethyl-1,2,4-triazoles and their 
antibacterial and antifungal activities. Heterocyclic Communications, 7, 577-582. 
 
Lawrence, C. B., Mitchell, T. K., Craven, K. D., Choi, Y., Cramer Jr., R. A., Kim, K. H., 
2008. At death’s door: Alternaria pathogenicity mechanism. Plant Pathology 
Journal, 24, 101-111.  
 
Lidenfelser, L. A., Ciegler, A., 1969. Experientia, 25, 719-720. 
 
Macías, F. A., Galindo, J. L. G., Galindo, J. C. G., 2007. Evolution and current status of 
ecological phytochemistry. Phytochemistry, 68, 2917-2936. 
  70 
 
Mann, J., 1987. Secondary Metabolism (2nd Edition). Clarendon Press, Oxford, pp. 303. 
 
Marinelli, F.,Zanelli, U., Rochi, V. N., 1995. Toxicity of 6-methoxymellein and 6-
hydroxymellein to the producing carrot cells. Phytochemistry, 42, 641-643. 
 
Matsumoto, M., Matsutani, S., Sugita, K., Yoshida, H., Hayashi, F., Terui, Y., Nakai, 
H.,Uotani, N., Kawamura, Y., Matsumoto, K., Shoji, J., Yoshida, T., 1992. 
Depudecin: A Novel Compound inducing the flat Phenotype of NIH3T3 Cells 
doubly transformed by ras-and src-Oncogene produced by Alternaria 
brassicicola. The Journal of Antibiotics, 45, 6, 879-885.  
 
Maude, R. B., Humpherson-Jones, F. M., 1980. Studies on the seed-borne phases of dark 
leaf spot (Alternaria brassicicola) and grey leaf spot (Alternaria brassicae) of 
Brassicas. Ann. appl. Biol., 95, 331-319. 
 
McDonald, V., Ingram, D. S., 1986. Towards the selection in vitro for resistance to 
Alternaria brassicicola (Schw.) Wilts., in Brassica napus ssp.Olefera (Metgz.) 
sinsk., winter oilseed rape. New Phytology, 104, 621-629.  
 
McKinnon, S. L., Keifer, P., Ayer, W. A., 1999. Components from the phytotoxic 
extract of Alternaria brassicicola, a black spot pathogen of Canola. 
Phytochemistry, 51, 215-221. 
 
Mehta, R. G., Liu, J., Constantinou, A., Hawthorne, M., Pezzuto, J. M., Moon, R. 
C.,Moriarty, R. M., 1994, Structure-activity relationships of brassinin in preventing 
the development of carcinogen - induced mammary lesions in organ culture. 
Anticancer Research, 14(3A), 1209-13. 
 
  71 
Mehta, R. G., Liu, J., Constantinou, A., Thomas, C. F., Hawthorne, M., You, M., 1995. 
Cancer chemopreventive activity of brassinin, phytoalexin from cabbage. 
Carcinogenesis, 16, 399-404. 
 
Mezencev, R., Kutschy, P., Salayova, A., Currillova, Z., Mojzis, J., Pilatova, 
M.,McDonald, J., 2008. Anticancer properties of 2-piperidyl analogues of the 
natural indole phytoalexin 1-methoxyspirobrassinol. Chemotherapy, 54, 5. 
 
Mezencev, R., Mojzis, J., Pilatova, M., Kutschy, P., 2003. Antiproliferative and cancer 
chemopreventive activity of phytoalexins: focus on indole phytoalexins of 
crucifers. Neoplasma, 50, 239-245. 
 
Monde, K., Katsui, N., Shirata, A.,Takasugi, M., 1990. Brassicanal A and B, Novel 
sulfur-containing phytoalexins from Chinese cabbage Brassica campestris L. ssp. 
pekinensis. Chemical Letters, 209-210. 
 
Monde, K., Sasaki, K., Shirata, A.,Takasugi, M., 1991. Brassicanal C and Two 
dioxindoles from cabbage. Phytochemistry, 30, 2915-2917. 
 
Monde, K., Takasugi, M., Shirata, A., 1995. Three sulfur containing stress metabolites 
from Japanese radish. Phytochemistry, 39, 581-2586. 
 
Müller, K. O., Börger, H., 1940. Experimentelle Untersuchungen über die Phytophthora-
Resistenz der Kartoffel. Arbeiten aus der Biologischen Reichsanstalt fur Land-
und Forstwirtschaft, Berlin-Dahlem, 23, 189-231.  
 
Niemann, G. J., 1993. The anthranilamide phytoalexins of the Caryophyllaceae and 
related compounds. Phytochemistry, 34, 319-328. 
 
Nurasaka, Y., Nurasaka, M., Seki, M., Ishida, J., Nakashima, M., Kamiya, A., Enju, A., 
Sakurai, T., Satoh, M., Kobayashi, M., Tosa, Y., Park, P., Shinozaki, K., 2003. 
  72 
The cDNA microarray analysis using an Arabidopsis pad3 mutant reveals the 
expression profiles and classification of genes induced by Alternaria brassicicola 
attack. Plant Cell Physiology, 44 (4), 377-387. 
 
Oka, K., Akamatsu, H., Kodama, M., Nakajima, H., Kawada, T., Otani, H., 2005. Host-
specific AB-toxin production by germinating spores of Alternaria brassicicola is 
induced by a host-derived oligosaccharide. Physiological and Molecular Plant 
Pathology, 66(1-2), 12-19. 
 
Otani, H., Kohnobe, A., Kodama, M., Kohmoto, K., 1998. Production of a host-specific 
toxin by germinating spores of Alternaria brassicicola. Physiological and 
Molecular Plant Pathology, 52, 285-295. 
 
Paxton, J. D., 1979. Elicitors of incompatible host responses: the role of host cell 
membranes. Recognition and Specificity in Plant Host-Parasite interactions, pp. 
153-163. 
 
Pedras, M. S. C., 2004. Prospects for controlling plant fungal diseases – Alternatives 
based on chemical ecology and biotechnology. Canadian Journal of Chemistry, 
82(9), 1329-1335. 
 
Pedras, M. S. C., Ahiahonu, P. W. K., 2005. Metabolism and detoxification of 
phytoalexins and analogs by phytopathogenic fungi. Phytochemistry, 66, 391-
411. 
Pedras, M. S. C., Ahiahonu, P. W. K., 2002. Probing the phytopathogenic stem rot 
fungus with phytoalexins and analogues: unprecedented glucosylation of 
camalexin and 6-methoxycamalexin. Bioorganic & Medicinal Chemistry, 10, 
3307-3312. 
Pedras, M. S. C., Ahiahonu, P. W. K., Hossain, M., 2004a. Detoxification of the 
cruciferous phytoalexin brassinin in Sclerotinia sclerotiorum requires an 
inducible glucosyltransferase. Phytochemistry, 65, 2685-2694. 
  73 
 
Pedras, M. S. C., Borgmann, I., Taylor, J. L., 1992. Biotransformation of brassinin is a 
detoxification in the “blackleg” fungus. Phytochemistry (Life Sci. Adv.), 11, 1-7. 
 
Pedras, M. S. C., Chumala, P. B., Suchy, M., 2003a. Phytoalexins from Thlaspi arvense, 
a wild crucifer resistant to virulent Leptosphaeria maculans, structure, synthesis, 
and antifungal activity. Phytochemistry, 64, 949-956. 
 
Pedras, M. S. C., Hossain, M., 2006, Metabolism of crucifer phytoalexins in Sclerotinia 
sclerotiorum: detoxification of strongly antifungal compounds involves 
glucosylation. Organic & Biomolecular Chemistry, 4, 2581-2590. 
 
Pedras, M. S. C., Jha, M., 2005. Concise syntheses of the cruciferous phytoalexins 
brassilexin, sinalexin, wasalexins, and analogues: expanding the scope of the 
Vilsmeier formylation. Journal of Organic Chemistry, 70, 1828-1834. 
 
Pedras, M. S. C., Jha, M., 2006. Toward the control of Leptosphaeria maculans: Design, 
syntheses, biological activity, and metabolism of potential detoxification 
inhibitors of the crucifer phytoalexin brassinin. Bioorganic & Medicinal 
Chemistry, 14, 4958-4979.  
 
Pedras, M. S. C., Jha, M., Ahiahonu, P. W. K., 2003b The synthesis and biosynthesis of 
phytoalexins produced by cruciferous plants. Curr. Org. Chem, 7, 1635-1647. 
 
Pedras, M. S. C., Khan, A. Q., 2000. Biotransformation of phytoalexin camalexin by the 
phytoapathogen Rizoctonia solani. Phytochemistry, 53, 59-69. 
 
Pedras, M. S. C., Khan, A. Q., Taylor, J. L., 1998. The phytoalexin camalexin is not 
metabolized by Phoma lingam, Alternaria brassicae, or phytopathogenic 
bacteria. Plant Science, 139, 1-8. 
 
  74 
Pedras, M. S. C., Liu, J., 2004. Designer phytoalexins: probing camalexin detoxification 
pathways in the phytopathogen Rhizoctonia solani. Journal of Organic 
Biomolecular.Chemistry, 2, 1070-1076. 
 
Pedras, M. S. C., Montaut, S., Suchy, M., 2004b. Phytoalexins from the crucifer 
rutabaga: Structures, syntheses, biosyntheses, and antifungal activity. Journal of 
Organic Chemistry, 69, 4471-4476. 
 
Pedras, M. S. C., Montaut, S., Xu, Y., Khan, A. Q., Loukaci, A., 2001. Assembling the 
biosynthetic puzzle of crucifer metabolites: indole-3-acetaldoxime is 
incorporated efficiently into phytoalexins but glucobrassicin is not. Chemical 
Communication, 1572-1573. 
 
Pedras, M. S. C., Okanga, F. I., 1998. Probing the pathogenic blackleg fungus with a 
phytoalexin homolog. Journal of Organic Chemistry, 63, 416-417. 
 
Pedras, M. S. C., Okanga, F. I., Zaharia, I. L., Khan, A. Q., 2000. Phytoalexins from 
crucifers: synthesis, biosynthesis, and biotransformation. Phytochemistry, 53, 
161-176. 
 
Pedras, M. S. C., Okanga, F. I., 2000. Metabolism of analogs of the phytoalexin 
brassinin by plant pathogenic fungi. Canadian Journal of Chemistry, 78, 338-
346. 
 
Pedras, M. S. C., Sarwar, M. G., Suchy, Mojmir., Adio, Adewale M., 2006a. The 
Phytoalexins from cauliflower, caulilexins A, B and C: Isolation, structure 
determination, synthesis and antifungal activity. Phytochemistry, 67(14), 1503-
1509. 
 
Pedras, M. S. C., Smith, K. C., 1997. Sinalexin, a phytoalexin from white mustard 
elicited by destruxin B and A. Phytochemistry, 67, 1503-1509. 
  75 
 
Pedras, M. S. C., Sorensen, J. L., Okanga, F. I.., Zaharia, I. L., 1999. Wasalexin A and 
B, new phytoalexins from wasabi: Isolation, synthesis, and antifungal activity. 
Bioorganic Medicinal Chemistry Letters, 9, 3015-3020. 
 
Pedras, M. S. C., Suchy, M., Ahiahonu, P. W. K., 2006b Unprecedented chemical 
structure and biomimetic synthesis of erucalexin, a phytoalexin from wild 
crucifer Erucustrum gallicum.Org. & Biomol. Chem, 4, 691-701. 
 
Pedras, M. S. C., Suchy, M., 2005. Detoxification pathways of the phytoalexins 
brassilexin and sinalexin in Leptosphaeria maculans: Isolation and synthesis of 
the elusive intermediate 3-formylindolyl-2-sulfonic acid. Organic and 
Biomolecular Chemistry 3, 2002-2007. 
 
Pedras, M. S. C., Taylor, J. L., 1991. Metabolic transformation of the phytoalexin 
brassinin by the blackleg fungus. Journal of Organic Chemistry, 56, 2619-2621. 
 
Pedras, M. S. C., Taylor, J. L., 1993. Metabolism of the phytoalexin brassinin by the 
blackleg fungus. Journal of Natural Product, 56, 731-738. 
 
Pedras, M. S. C., Zaharia, I. L., 2000. Sinalbins A and B, phytoalexins from Sinapis 
alba: elicitation, isolation, and synthesis. Phytochemistry, 55, 213-216. 
 
Pedras, M. S. C., Zheng, Q-A., Gadagi, R. S., 2007b. The first naturally occurring 
aromatic isothiocyanates, rapalexins A and B, are cruciferous phytoalexins. 
Chemical Communications, 1848-1850. 
 
Pedras, M. S. C., Zheng, Q-A., Sarma-Mamillapalle, V. K., 2007a. The phytoalexins 
from Brassicaceae: Structure, Biological Activity, Synthesis and Biosynthesis. 
Natural Product Communications, 2(3), 319-330. 
 
  76 
Pedras, M. S. C., Khan, A. Q., Smith, K. C., Stettner, S. L., 1997. Preparation, 
biotransformation, and antifungal activity of methyl benzyldithiocarbamates. 
Canadian Journal of Chemistry, 75, 825-828. 
 
Pedras, M. S.C., Zheng, Q-A., Gadagi, R. S., Jha, M., Sarma-Mamillapalle, V. K., 
2007d. Detoxification of the phytoalexin brassinin by isolates of Leptosphaeria 
maculans pathogenic on brown mustard involves an inducible hydrolase. 
Phytochemistry, 68, 1572-1578. 
 
Pedras, M. S.C., Zheng, Q-A., Sarwar, G. M., 2007c. Efficient synthesis of brussalexin 
A, remarkable phytoalexin from Brussels sprouts. Organic Biomolecular 
Chemistry, 5, 1167-1135. 
 
Pedras, M. Soledade C., 2008. The chemical ecology of crucifers and their fungal 
pathogens: Boosting plant defenses and inhibiting pathogen invasion. Chemical 
Record, 8(2), 108-115. 
 
Pilatova, M., Sarrisky, M., Kutschy, P., Mirrosay, A., Mezencev, R., Curillova, Z., 
Suchy, M., Monde, K., Mirossay, L., Mojzis, J., 2005. Leukemia Research, 29, 
415-421. 
 
Rangel, J. F., 1945. Two Alternaria diseases of cruciferous plants. Phytopathology, 35, 
1002-1007. 
 
Rotem, J., 1994. The Genus Alternaria. Biology, Epidemiology, and Pathogenicity. APS 
press, St. Paul, USA. 
 
Sassa, T., Negoro, T., Ueki, H., 1972. Production and characterization of a new fungal 
metabolite, cotylenol. Agriculturaland Biological Chemistry, 36 2281-2285. 
 
  77 
Smith, C. J., 1996. Accumulation of phytoalexins: defence mechanism and stimulus 
response system. New Phytologist, 132, 1-45. 
 
Suri, R. A. and Mandahar, C. L., 1984. Experientia, 40, 462. 
 
Takasugi, M., Katsui, N., Shirata, A., 1986. Isolation of three novel sulfur-containing 
phytoalexins from the Chinese cabbage Brassica campestris L. ssp. pekinensis 
(Cruciferae). Journal of the Chemical Society, Chemical Communications, 1077-
1078. 
 
Talalay P, Fahey J. W., Holtzclaw W. D., Prestera, T., and Zhang, Y., 
1995.Chemoprotection against cancer by phase 2 enzyme induction. Toxicology 
Letters, 82, 173-179. 
 
Theologis, A., Ecker, J. R., Palm, C. J., Federspiel, N. A., Kaul, S., White, O., Alonso, 
J., Altafi, H., Araujo, R., Bowman, C. L., Brooks, S. Y., Buehler, E., Chan, A., 
Chao, Q., Chen, H., Cheuk, R. F., Chin, C. W., Chung, M. K., Conn, L., Conway, 
A. B., Conway, A. R., Creasy, T. H., Dewar, K., Dunn, P., Etgu, P., Fedlblyum, 
T. V., Feng, J., Fong, B., Fujii, C. Y., Gill, J. E., Goldsmith, A. D., Haas, B., 
Hansen, N. F., Hughes, B., Hulzar, L., Hunter, J. L., Jenkins, J., Johnson-
Hopson, C., Khan, S., Khaykin, E., Kim, C. J., Koo, H. L., Kremenetskala, I., 
Kurtz, D. B., Dwan, A., Lam, B., Langin-Hooper, S., Lee, A., Lee, J. M., Lenz, 
C. A., Li, J. H., Li, Y., Lin, X., Liu, S. X., Liu, Z. A., Luros, J. S., Malti, R., 
Marziall, A., Militscher, J., Miranda, M., Nguyen, M., Nierman, W. C., Osborne, 
B. I., Pal, G., Peterson, J., Pham, P. K., Rizzo, M., Rooney, T., Rowley, D., 
Sakano, H., Salzberg, S. L., Schwartz, J. R., Shinn, P., Southwick, A. M., Sun, 
H., Tallon, L. J., Tambunga, G., Toriumi, M. J., Town, C. D., Utterback, T., 
VanAken, S., Vaysberg, M., Vysotskala, V. S., Walker, M., Wu, D., Yu, G., 
Fraser, C. M., Venter, J. C., Davis, R. W., 2000. Sequence and analysis of 
chromosome 1 of the plant Arabidopsis   thaliana. Nature, 408, 816-820. 
 
  78 
Thomma, B. P., Nelissen, I., Eggermont, K., Broekaert, W. F., 1999. Defficiency in 
phytoalexin production causes enhanced susceptibility of Arabidopsis thaliana to 
the fungus Alternaria brassicicola. The Plant Journal, 19, 163-171. 
 
Tsuji, J., Jackson, E. P., Gage, D. A., Hammerschmidt, R., Somerville, S. C., 1992. 
Phytoalexin accumulation in Arabidopsis thaliana during the hypersensitive 
reaction to Pseudomonas syringae. Plant Physiology, 98, 1304-1309.  
 
Verma, P. R., Saharan, G. S., 1994. Monograph on Alternaria diseases of crucifers. 
Saskatoon Research Center, Agriculture and Agri-Food Canada. 
 
